EP1924711A2 - Nucleic acid-binding chips for detecting nitrogen deficiencies as part of bioprocess control - Google Patents

Abstract

The invention relates to nucleic acid-binding chips for monitoring bioprocesses, specifically for detecting nitrogen deficiencies. Said chips carry probes that are sensitive to at least three of the following 50 genes: kdgR, citA, htrA, ycnl, yppF, trpB, ggt, alsR, glnA, nrgA, yciC, yvtA, nrgB, ycnJ, glnR, yvIA, yncE, yvlB, trpF, ydfS, trpD, ycnK, trpB, trpC, nasD, ycdH, nasC, nasB, trpE, pckA, nasF, yrkC and tnrA or the homologs to SEQ ID NO. 91, 41, 53, 19, 55, 47, 21, 17, 9, 85, 45, 49, 95, 63, 15, 93 or 81 at a maximum of 80 different probes that are specific of nitrogen metabolism. The invention also relates to the use of corresponding gene probes, especially on the aforementioned chips, to corresponding methods and possible uses.

Description

Nucleic acid-binding chips for the detection of nitrogen deficiency states in the context of

bioprocesses

The present invention relates to nucleic acid-binding chips for monitoring bioprocesses with a particular focus on the detection of nitrogen deficiency states and to the use of corresponding gene probes, in particular on such chips, or methods and applications based on such probes and chips

In the technical use of biological processes, there is the very fundamental problem of monitoring their progress in order to achieve the desired result, to save resources and / or to achieve an optimal result in a given time Microorganisms on an agar plate or in Schuttelkultur to understand, but in particular their fermentation, or the extraction of raw materials via the fermentation of microorganisms There is a rich state of the art, both unicellular eukaryotes such as yeasts or streptomycetes, as well as what gram-negative or gram-positive bacteria As for

The monitoring of such processes (monitoring) is done on the one hand by observing the changing properties and requirements of the organisms under consideration during the process, which is reflected, for example, in the optical density and viscosity of the medium, in absorbed or emitted gases, in changes in the pH This can also be used to measure enzymatic activities by means of suitable assays, for example the detection of activities of interest in the cultural supernatant

On the other hand, in recent years, various techniques have been developed to track the metabolic processes of the organisms concerned at the level of gene expression. A common method for this is the use of genes for easily detected proteins as indicators of the activity of the promoters for the actually genes of interest ( Promoter analysis, gene expression analysis) For this purpose, appropriate apparatuses (so-called (Biko) sensors) have been developed

Other techniques are concerned with the detection of the proteins of interest or of the mRNA coding for these proteins. These include (1) the proteome analysis, that is, the consideration of the change in the equipment of the cells in question with proteins, which mostly via 2-dιmensιonale gel electrophoresis of the cell lysates (2) the analysis of the generated mRNA (Transkπptom) via an analogously created "genomic DNA array" and (3) the chip technology The latter is at a relatively early stage of development While the two former methods are ultimately based on quantitative isolation and time-consuming analyzes of the macromolecules in question, chip technology is based on the principle of attaching probes to proteins or nucleic acids on physically readable carriers (chips). The directly on the presence of the respective proteins or nucleic acids respond Compared to the two first-mentioned technologies, one promises of such chips a timely to the process considered analysis (/ W - // ne analysis) Em further advantage is the need for comparatively small amounts of sample

The principle of chip-based measurements is described, for example, in the article "Real-time electrochemical monitoπng towards green analytical chemistry" by J Wang (Acc Chem Res, ISSN 0001-4842, Rec Sept 12, 2001, pages A-F) schematically in FIG Accordingly, the sample to be analyzed is brought into contact with a recognition layer (biorecognition layer), which can be, for example, an enzyme, antibody, receptor or DNA, the signal received via a transducer, for example an amperometric or potentiometπsche electrode, output via an amplifier (amplification / processing) as an electrical voltage or as an electrical potential in the work in question and optical systems are addressed to which the electronically evaluable systems in terms of Miniatuπsierbarkeit and other advantages the author seemed more favorable

Due to the present invention, the protein-specific chips can be disregarded. MRNA-recognizing chips are usually doped with complementary DNA molecules or DNA analogs. Their preparation and use for very detailed questions, such as the differentiation of point mutations, for example, in the application WO 95/11995 A1. Among the DNA chip analyzes there are those with a PCR amplification of the target sequence and those without amplification. Furthermore, there are those with optical evaluation of the signals due to the recognition and those with electrical evaluation

For this purpose, for example, fluorophores, Acπdiniumester or indirect detection of secondary binding processes, for example on biotin, avidin / streptavidin or digoxigenin described in the latter case, digoxigenin-specific antibodies are used for optical detection, the In this case, the enzyme activity is detected either koloπmetrisch or luminescence According to Westin et ai (2000), Nature Biotechnol, Volume 18, S 199-204, the hybridization with a PCR on the DNA chip be coupled so as to be able to carry out the entire detection reaction on a chip can ("Lab-on-a-Chιp concept")

Further work describes the development of DNA chips that miniaturize the principle of capillary electrophoresis for DNA sequencing, or separation (Woolley and Mathies (1994), Proc Natl Acad Sei, Volume 91, S 11348-11352, Liu et al (2000) Proc Natl Acad Sci., Vol. 97, pp. 5369-5374)

Electrically readable DNA chips have in principle already been introduced in some publications (Hoheisel (1999), DECHEMA Annual Report 1999, pp 8-11, Hintsche et al (1997), EXS, vol 80, p 267-283) Wπght et al (2000 , Anal Biochem, Vol. 282, pp 70-79) used a "lon channel sensor" (ICS) for DNA detection as first described by Cornell et al. (1997, Nature, Vol. 387, pp. 580-583) This is a method of detecting the conductivity of molecular ion channels by a binding reaction. Essentially, the sensor is an impedance element. Cheng et al (1998, Nat Biotechol, Vol. 16, pp. 541-546) states that electrical impulses are used to enhance the hybridization reaction on optical DNA chips Fπtsche et al (2002, Laborwelt II) proposed an electrical chip system that works with metallic nanoparticles bound to oligonucleotides, for example so- called "metallic amplification" during the Hybπdisierungsreaktion triggered a drop in electrical resistance at the electrode, which is then measured as a signal

Another approach is based on an electrical detection pnnzip in which DNA probes are used, which leads by labeling with a suitable enzyme (for example, alkaline phosphatase) after Hybπdisierung to an electrically active substrate, which then by a redox reaction at the Electrode is detectable (Hintsche et al (1997), EXS, Volume 80, S 267-283)

If one has decided with regard to the basic structure and the evaluation system for a particular type of nucleic acid-recognizing chip type, the more concrete problem arises, which gene activities should be observed. It should be remembered that in the number of with a Nukleιnsaure-Chιp type At the same time analyzable genes technically conditional limits Thus, optically readable chips, which is the number of probes that can be applied to the chip, the electrically evaluable currently superior Their limits are set by the Miniatunsierbarkeit the electronic measuring units

Thus, the biological problem arises, which selection of gene activities mimics the considered process in a suitable way. This also includes the monitoring of product formation, At the same time, control genes can also be included to indicate when the process is developing in a direction that is not intended. In the course of this monitoring, for practical reasons, a not too high number of different genes should be observed

Of particular technical interest are biotechnological processes with gram-positive bacteria. For these are used especially for their ability to secretion for the industrial production of valuable materials. These include those of the genus Bacillus and of these, in turn, the species S subtihs, B amyloliquefaciens, B agaradherens, B licheniformis, B lentus and B globign currently the most economically significant

The simultaneous observation of the activity of several genes in bacteria (multiparameter detection), for example, deals with the work presented below. In the article "Monitoring of genes that respond to process-related stress in large-scale bioprocesses" by Schweder et al (1999), Biotech Bioeng, Vol. 65, pp 151-159, discloses the change in mRNA levels of various stress-inducible genes, namely clpB, dnaK (induced in heat shock), uspA (glucose deficiency), proU (osmotic stress), pfl and frd (O ₂ deficiency) and ackA (glucose excess) in the course of a fermentation of E coli and in the subsequent concentration phase. They were detected by a PCR-based method carried out in a conventional manner. Different expression rates were already observed at different sites of the reactor and in a matter of seconds reactions to changed conditions

Another fermentation of E. coli is described in the work "Monitoring of genes that respond to overproduction of an insoluble recombinant protein in Escherichia coli glucose-limited fed-batch fermentations" by Jürgen et al (2000), Biotech Bioeng, vol. 70, p. 217 -224, described Here, the expression of the genes ion, dnaK, ibpB, htrA, ppiB, groEL, tig, s6, 19 and dps, partly on mRNA, partially on protein level, partly on both levels considered the study was done on 2D PAGE, or the DNA Array Technique In view of the results, it is proposed to follow recombinant bioprocesses such as heterologous protein production via (directly) process-relevant proteins and reporter genes such as ibpB

The work "Genomic analysis of high-cell-density recombinant Escherichia coli fermentation and cell conditioning for improved recombinant protein yield" by RT GiII et al. (2001) is further concerned with a further observation of the course of fermentation on expression of a recombinant protein by E. coli. Biotech Bioeng, Vol. 72, pp. 85-95). It is described herein that the stress genes degP, uvrB, alpA, mltB, recA, ftsH, ibpA, aceA and groEL are more strongly expressed under high cell density low cell density conditions The strength of Reaction after clustered among themselves into certain clusters. This was determined by a RT-PCR and DNA microarray-based and dot-blot added approach applied to samples from two fermentation times just at low cell density and towards the end with high cell density. From this, "cell conditioning" approaches have been developed to reduce the stress response of the cells

Fundamental differences in the expression patterns of Gram-positive organisms over those of Gram-negative bacteria are discussed in the work "Proteome and transcnptome based analysis of Bacillus subtilis cells overproducing an insoluble heterologous protein" by Jürgen et al (2001), Appl Microbiol Biotechnol, Vol. 55, p. 332 Uncovered the expression of the genes dnaK, groEL, grpE, cIpP, clpC, clpX, rpsB and rplJ in B subtilis, as determined by the DNA-macro-array technique or two-dimensional polyacrylic gel electrophoresis Thus, in Gram-positive bacteria used for overexpression, the genes for purine and pyrimidine synthesis as well as the specific nbosomal proteins are more strongly expressed than would be expected on the basis of the findings on Gram-negative bacteria. Another difference concerns the proteases Lon and Clp

Individual of these genes or even nucleic acid-binding chips with individual of these genes are now disclosed in several publications, or at least the possibility of their production demonstrated Thus, for example, the two patent applications DE 10136987 A1 and DE 10108841 A1 each reveal a gene from Corynebacterium glutamicum, namely clpC or citB Both genes are described as relevant for the amino acid metabolism, which is why a commercially interesting use of these genes should consist in inactivating or at least attenuating them in order to optimize the fermentative production of amino acids by this microorganism. Further application possibilities can then exist according to these applications. Submit probes for the relevant gene products on nucleic acid-binding chips

On the other hand, more and more genome data of various organisms are published which contain such a wealth of sequence data that a representative selection appears desirable. Thus, patent application WO 02/055655 A2 discloses more than 1,800 DNA sequences obtained by the complete sequencing of the Genome of the microorganism Methylococcus capsulatus have been identified

For example, the entire genome of gram-positive bacillus likemformis has also been sequenced. It is described in the publication "The Complete Genome Sequence of Bacillus Lichemformis DSM 13, on Organism with Great Industrial Potential" (2004) by B Veith et al in J Mol Microbiol Biotechnol. Volume 7 (4), pages 204 to 211, described and is additionally under entry AE017333 (bases 1 to 4 222 645) in the database GenBank (National Center for Biotechnology Information NCBI, National Institutes of Health, Bethesda, MD, USA, http://www.ncbi nlm nih gov, Booth 2 12 2004)

Using the technology of optically evaluable chips, it is now even possible to produce nucleic acid-binding chips that cover an almost complete genome or the associated transcptome (genomic DNA chips).

The application WO 2004/027092 A2 provides a representative cross-section with a manageable number of genes in order to identify various physiological states which an observed microorganism can undergo during cultivation. For example, these include starvation conditions for various nutrients or stress situations such as for example heat or cold shock, shear stress, oxidative stress or oxygen limitation These are the following genes acoA, ahpC, ahpF, citB, clpC, cIpP, codY, cspA, cspB, of, dnaK, eno, glnR, groEL, groL, gsiB, ibpA, ibpB, katA, catE, IctP, Idh, opuAB, phoA, phoD, pstS, purC, purN, pyrB, pyrP, sigB, tnrA, trxA and ydjF. From this application, the corresponding DNA sequences are also derived from β subtihs As a result, it has become possible to also produce corresponding nucleic acid-binding chips that are used in monitoring microorganisms Smen, in particular Gram-positive or Gram-negative bacteria-based bioprocesses indicate changes in the metabolic activities characterizing this process

Nucleic acid-binding chips that are based on this selection of genes provide a certain, but overall rather rough overview of the respective metabolic situation. They usually are not able to particularly illuminate a single sub-problem, however, a single positive signal can be different Be situations out or even be false positive, which is why it often - and especially in such an unclear situation - makes sense to analyze a selected metabolic aspect separately On the other hand, especially in electrically readable nucleic acid-binding chips, which have the advantage of a timely analysis, the Number of simultaneously assignable places limited, so that can not be easily applied additional gene probes to detect additional, specific metabolic situations

From the non-prepublished applications DE 102004061664 7 and DE 102005022145 9 nucleic acid-binding chips for monitoring bioprocesses with a special focus on the detection of phosphate deficient states or glucose deficiency states respectively carry a limited number of probes to indicate these specific stress situations A metabolic situation, which can be critical for microorganisms and thus critical for a corresponding bioprocess, is that of nitrogen deficiency because nitrogen is an essential element for nucleic acids and amino acids and thus for proteins, which in turn represent the main function and building materials of biological organisms a lack of building material supply and can rapidly lead to the death of the cells or at least prevent the achievement of higher cell densities Especially in the fermentative production of proteins, such as technical enzymes, a nitrogen deficiency also affects the product formation rate Thus, there is a particular need, in this regard, a chip to carry out a based, timely analysis and to be able to intervene punctually and thus more purposefully in the ongoing bioprocess due to the result that can be obtained quickly This was made possible by a nitrogen bottleneck that was not recognized or realized too late

It was therefore the task of identifying genes that can be as clearly as possible associated with the stress signal of nitrogen deficiency in organisms, in particular microorganisms. The aim was to develop probes for these genes in order to use them for the monitoring of corresponding bioprocesses to be able to

Thus, it should be possible to prove nucleic acid-containing chips with gene probes for single or several of these genes and thereby arrive at nucleic acid-binding chips that reliably indicate the signal "nitrogen deficiency" in the course of a monitored bioprocess (nitrogen deficiency sensors) was particularly suitable for those nucleic acid-binding chips whose number of assignable sites is comparatively low due to their design, in particular the electrically evaluable For these, on the other hand, have the advantages of rapid readability and thus enable an / A - // ne analysis This ensures if necessary early intervention in order to optimize the bioprocess concerned with regard to the supply of building materials

Such a DNA-binding chip should be usable for several comparable processes and be adapted to specific application possibilities with comparatively slight variations. Preferably it should be based on bioprocesses on the basis of saccharomyces, in particular B subtilis, B amyloliquefaciens, B lentus, B globign, and be especially geared to ß licheniformis Bioprocesses focused on fermentations, in particular the technical production of products, especially overexpressed proteins Furthermore, such a nitrogen deficiency sensor should allow appropriate methods for measuring the physiological state of the cells under consideration, as well as appropriate uses for monitoring the biological processes under consideration

To solve this problem, a variety of genes from the biotechnologically important bacterium B lichemformis was examined in terms of their activability by the transition of the relevant culture in a nitrogen deficiency state (Example 1) It was surprisingly found that by far not all genes involved in nitrogen metabolism In addition, surprisingly, activation of such genes has been observed that have not been readily implicated in nitrogen metabolism, such as the putative malate synthase gene, or those of unknown type Furthermore, those genes were to be subtracted therefrom which clearly respond to more than just this one stress signal. The genes identified in this way should now, if appropriate independently of their function hitherto known, be known as nitrogen According to the teaching of the present invention, genes are all the more suitable as indicators the more severely this response fails. According to the invention, therefore, such genes are selected as nitrogen deficiency indicators clear signal significantly above a certain threshold value. The further the result is, the more they are to be regarded as parts of the solutions of the task according to the invention, which explains a corresponding staggering of the preferred inventionapplications (see below).

Table 1 shows all of the 210 genes of Bacillus lichemformis DSM13 identified in Example 1, the induction of which was observed under nitrogen deficiency, with a factor of at least three being considered significant. Of these, in table 2, all 49 genes are assembled whose induction by nitrogen deficiency is any of those measured Time points have been at least the factor 8 and where it could be concluded from parallel, not shown here studies that they were relatively specific for this signal These are listed in Table 3 again in terms of strength of their observed maximum induction their DNA and amino acid sequences listed in the sequence listing for the present application, wherein the odd-numbered numbers for DNA and the subsequent even-numbered for the respective deduced amino acid sequences stand on these sequences also refer to the respective SEQ ID numbers in Tables 2 and 3 acts these are the following genes, in order of decreasing strength of the nitric-depleted induction (see Tables 2 and 3) - Gene coding for a hypothetical protein of unknown function (homolog to SEQ ID

NO 81, 82),

-yrkC (unknown function - similar to proteins of unknown function, SEQ ID NO 83, 84), - nasF (Uroporphyπn-III C-methyltransferase, SEQ ID NO 39, 40), - for a putative protein (putative nitrogen regulatory protein P-) Il) coding gene (homolog to SEQ ID NO 93, 94),

- pckA (phosphoenolpyruvate carboxykinase, SEQ ID NO 43, 44), - trpE (anthranilate synthase, SEQ ID NO 67, 68), - nasB (electron transfer subunit of assimilatory nitrate reductase, SEQ ID NO 33,

34), - coding for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS)

Gene (homologue to SEQ ID NO 15, 16),

-nasC (catalytic subunit of the assimilatory nitrate reductase, SEQ ID NO 35, 36), -ycdH (unknown function - similar to the binding protein of the ABC transporter, SEQ ID

NO 65, 66), - gene coding for a putative protein (putative ammonium transporter) (homolog to SEQ

ID NO 63, 64),

- nasD (subunit of assimilatory nitritetrase, SEQ ID NO 37, 38), - gene coding for a hypothetical protein of unknown function (homologue to SEQ ID

NO 95, 96), - coding for a putative protein (putative Na (+) - linked D-alanine glycine permease)

Gene (homolog to SEQ ID NO 49, 50), gene coding for a putative protein (putative malate synthase, EC 4 1 3 2) (homolog to SEQ

ID NO 45, 46), gene coding for a putative protein (putative glycosyl hydrolase / lysozyme) (homolog

SEQ ID NO 85, 86), gene encoding a putative protein (putative serine protease) (homologue to SEQ ID NO 9,

10), gene coding for a putative protein (putative transcription regulator) (homolog to SEQ

ID NO 17, 18),

- trpC (indole-3-glycerol phosphate synthase, SEQ ID NO 71, 72), - tφB (beta subunit of tryptophan synthase, SEQ ID NO 75, 76), -ycnK (unknown function - similar to the transcriptional regulator of DeoR- Family, SEQ ID

NO 31, 32), gene coding for a putative protein (putative phage capsid proteme) (homolog to SEQ

ID NO 21, 22), - trpD (anthranilate phosphonobosyl transferase, SEQ ID NO 69, 70), -ydfS (unknown function - similar to proteins of unknown function, SEQ ID NO 79, 80),

trpF (phospho-tosyl-anthranilate isomerase, SEQ ID NO 73, 74),

- gene coding for a putative protein (putative hydrolase) (homologue to SEQ ID NO 47, 48),

-yvlB (unknown function - similar to proteins of unknown function, SEQ ID NO 89, 90),

-yncE (unknown function, SEQ ID NO 87, 88),

-yvIA (unknown function, SEQ ID NO 97, 98),

glnR (transcriptional repressor of the glutamine synthetase gene, SEQ ID NO 11, 12),

-ycnJ (unknown function - similar to the copper export protein, SEQ ID NO 29, 30),

for a putative protein (ATP Bιndungsproteιn a putative ABC T ransporters) coding

Gene (homologue to SEQ ID NO 55, 56), - gene coding for a conserved hypothetical protein of unknown function (homolog to

SEQ ID NO 19, 20),

nrgB (nitrogen-regulated Pll-like protein, SEQ ID NO 3, 4),

-yvtA (unknown function - similar to HtrA-like secretion, SEQ ID NO 23, 24), -yciC (unknown function - similar to proteins of unknown function, SEQ ID NO 57, 58), - nrgA (ammonium transporter, SEQ ID NO 5, 6), -glnA (glutamine synthetase, SEQ ID NO 13, 14),

- alsR (transactivation regulator of the alpha acetolactate operon, SEQ ID NO 61, 62), - ggt (gamma glutamyl transpeptidase, SEQ ID NO 51, 52), -yqjN (unknown function - similar to amino acid degradation, SEQ ID NO 1 , 2), -yppF (unknown function, SEQ ID NO 77, 78), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID

NO 53, 54), - gene coding for a hypothetical protein of unknown function (homolog to SEQ ID

NO 41, 42),

-ycnl (unknown function - similar to proteins of unknown function, SEQ ID NO 27, 28), - htrA (Sennprotease Do, heat shock protein, SEQ ID NO 7, 8), - for a putative protein (putative ABC transporter / amino acid permease ) coding gene

(Homologue to SEQ ID NO 91, 92), - citA (minor citrate synthase I, SEQ ID NO 59, 60), - kdgR (transcriptional repressor of the pectin degradation operon, SEQ ID NO 25, 26)

Further investigations (see Example 5) showed that the following gene is also suitable according to the invention as an indicator

tnrA (a global transcriptional regulator involved in nitrogen metabolism regulation, SEQ ID NO 99, 100) A solution of the problem is thus in a nucleic acid-binding chip, doped with probes for at least three of the following genes kdgR, citA, for a putative protein (putative ABC transporter / amino acid permease) coding gene (homolog to SEQ ID NO 91), MrA, ycnI, gene coding for a hypothetical protein of unknown function (homolog to SEQ ID NO 41), gene coding for a hypothetical protein of unknown function (homolog to SEQ ID NO 53), yppF, yqjN, ggt, as R, glnA, nrgA, yciC, yvtA, nrgB, gene encoding a conserved hypothetical protein of unknown function (homologue to SEQ ID NO 19), gene encoding a putative protein (ATP binding protein of a putative ABC transporter) (homologue to SEQ ID NO 55), ycnJ, glnR, yvIA, yncE, yvlB, for a putative protein (putative hydrolase) encoding gene (homologue to SEQ ID NO 47), trpF, ydfS, trpD, for a putative protein (putative phage capsid proteme) coding gene (homolog to SEQ ID NO 21), ycnK, trpB, trpC, gene coding for a putative protein (putative transcriptional regulator) (homologue to SEQ ID NO 17), gene encoding a putative protein (putative serine protease) (homologue to SEQ ID NO 9 ) gene coding for a putative protein (putative glycosyl hydrolase / lysozyme) (homologue to SEQ ID NO 85), gene encoding a putative protein (putative malate synthase, EC 4 1 3 2) (homologue to SEQ ID NO 45), for a putative protein (putative Na (+) - linked D-alanine glycemic permease) encoding gene (homologue to SEQ ID NO 49), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO 95), nasD, for a putative protein (putative ammonium transporter) encoding gene (homologue to SEQ ID NO 63), ycdH, nasC, gene coding for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) (homologue to SEQ ID NO 15), nasB, trpE, pckA , for a putative protein (putative particulate regulatory protein in P-Il) gene encoding (homologue to SEQ ID NO 93), nasF, yrkC, gene coding for a hypothetical protein of unknown function (homologue to SEQ ID NO 81), tnrA, where the total number of all nitrogen metabolism specific Probes not above 80

Detailed information on these genes can be found in Examples 1 to 3 and Tables 1 to 3 of the present application. In the Sequence Listing, these genes are disclosed as obtainable from β licheniformis DSM 13. Most of these are also described from other species (see below) ) Some, however, are putative (presumed / presumed) genes or genes coding for putative (assumed / presumed) enzymes. According to the invention, these are as far as possible based on database comparisons as having a putative (assumed) function and additionally defined as a homologue to the found B ichicheniformis genes. Two things have to be explained here

- On the one hand, it might turn out for one or another, through a biochemical analysis, that this putative function does not match the real function Rather, these findings do not question the invention in that it depends solely on the observation of the increased transcription in connection with the nitrogen deficiency, so that the gene activity in question, regardless of the ultimate enzyme activity is quite an indicator of Nitrogen deficiency can serve

On the other hand, in the absence of a gene name, no more suitable definition could be found than that about the gene itself. This is why it is spoken by homologues It can be assumed that in species other than B. licheniformis the homologous genes are activated under nitrogen deficiency In a species of interest for one of these genes, there are several homologs capable of transcoding in vivo, the term "homologue to SEQ ID NO" refers to the closest of these various candidate genes

According to the invention, at least three of these genes are selected in order to obtain as reliable a statement as possible, that is, to exclude a single false-positive signal due to only one type of probe

According to the invention, a nucleic acid-comprising chip means all articles which are provided with nucleic acid-specific probes and in each case deliver an evaluable signal upon binding of one or more specifically recognized nucleic acids

In principle, they can all be used for embodiments of the present invention. They are based on the principle of nucleic acid hybridization of the mRNA to be detected (or a derivative thereof derived from it) Molecule) with the probe presented on the chip Depending on the system for evaluating the signal released by the hybridization, a distinction is made between chips having an optical system and an electrical analysis system. In principle, both systems can be used

Such chips are used in the following manner to control (monitor) the bioprocess under consideration. From the process, a sample is taken with the biological material to be analyzed at a certain time. From this, RNA is isolated by methods known per se, for example cell disruption and use of a denaturing buffer. in particular mRNA isolated. This is itself labeled or used as the starting molecule for a molecule introduced into the measurement (for example cDNA obtained by reverse transcription) and the resulting molecules are advantageously passed over / through the chip in a buffer on hybridization (sandwich labeling) of a prepared RNA or its derivative with the homologous (that is, congruent in terms of their sequence) on the chip provided probe (target nucleic acid, for example, target DNA or target nucleic acid analog) results in a corresponding optically or electronically evaluable signal This is based for example on the labeling of the binding mRNA or a transcript thereof with a staining or fluorescent marker, a hybridization with a second Probe or on a secondary detection reaction, such as via RT-PCR

Since in each case several molecules are bound to the chip by the same probe, the strength of the hybridization signal over a certain range - optionally to be optimized in individual cases - is proportional to the number of specific mRNA present in the sample at the time of sampling in this way the strength of the signal provides a direct measure of the activity of the gene in question at the time of sampling

The time interval between sampling and measurement should be kept as short as possible, for example via a largely automated sampling, their processing and management via / through the sensor

When using a chip according to the invention considered (monitoπerte) organisms are in principle all plants, animals and microorganisms in question, especially those that are used commercially Thus, for example, from the application DE 19860313 A1 entitled "Process for the detection and characterization of active compounds against plants Pathogens "show that there are metabolic situations in plants, especially useful plants, which must be observed. Likewise, for example, livestock or laboratory animals can be observed Of not minor commercial interest are eukaryotic cell cultures, such as in the production of monoclonal antibodies, and in particular the fermentative production of food About the alcoholic fermentation operated by yeasts Bacteria are used in particular for the technical production of proteins or low-molecular valuable substances (biotransformation), for example of vitamins or antibiotics

According to the invention, probes are to be understood as meaning all molecules which are capable of reacting (binding) with nucleic acids. In the context of a corresponding arrangement (chip), this interaction is exploited to provide a signal which can be assigned to a significant extent to obtain

From a chemical point of view, a probe according to the invention is usually a compound capable of binding mRNA molecules or nucleic acids derived therefrom via hydrogen bonds, as for example also in the interaction of the two strands of a DNA or the DNA RNA This may, for example, be a DNA which is more stable to hydrolysis than RNA In addition, other molecules are known in the prior art, in particular chemically synthesized biomimetic allow the same interaction, but are more stable than DNA, for example, in that the phosphate ester bonds of the backbone have been exchanged for less hydrolysempfmdliche bonds Such nucleic acid analog Preferred probes of the present application (see below) The specific probes in question were to be synthesized according to the example of the sequence listing associated with this application. This is in contrast to the aspect that chips according to the invention should advantageously be usable several times, in particular during a single observed process, in the course of which constant monitoring is desirable

The degree of homology between the probe provided and the mRNA or the nucleic acid derived therefrom, which is to be recognized by hybridization, is ultimately limiting for the usefulness of a probe. Ultimately, the degree of hybridization of the probe with the mRNA to be detected is decisive (see above). on their usefulness as a probe and must be experimentally optimized in individual cases and / or considered by adjusting the signal evaluation There must be under the conditions imposed by the structure of the measuring apparatus, and other influences, a hybridization that can be specifically attributed only to the gene of interest is sufficiently strong to give a positive signal, and on the other hand is not too strong, as that the recognized molecule diffuses again after generation of the signal to free the binding site for the next molecule, or to allow the signal to decay, the latter given if necessary via a corresponding washing step

However, it is necessary to estimate the degree of homology between the genes in question before using the chips according to the invention for an organism of interest, anchoring such on the same genes of more closely related species on the chip if the affinity of the mRNAs to be detected for the probes present is insufficient, and Calibration measurements to obtain reliable information on which signal strength corresponds to which concentration of specific mRNA

Identification of the 50 genes essential to the present invention is described in the examples of the present application. The sequences obtainable from β licheniformis are given in the Sequence Listing of the present application (SEQ ID NOs. 1 to 100), wherein the odd-numbered sequences are While the DNA sequences can be used directly for the production of probes (see above), the amino acid sequences serve, for example, via sequence data base sequences and DNA sequences which are each higher by a number higher sequences around the respectively derived amino acid sequences. Comparisons of gene function testing can also be used to generate similar nuclear acid-detecting probes through backward translation of the genetic code

As shown in Example 1, numerous different gene transcripts, that is, mRNA molecules, in particular those of which participation in nitrogen metabolism was well known, were investigated. These mRNA molecules became a nitrogen deficient state at various times during the transition from B licheniformis DSM13 In Example 1 it is also described how the concentration increase of this mRNA in the cell interior of B licheniformis was determined experimentally. Alternative determination possibilities for this may be established in the prior art. The compilation in Table 1 (Example 2) is crucial to the understanding of the present invention shows the concentration changes associated with the transition for a total of 210 mRNAs. The following threshold values for the ratio of the amount of RNA of the respective gene to the control value were regarded as significant. whose RNA has a ratio of> 3 (ie at least tripling), a clear induction is present at a ratio of> 10, genes with an RNA ratio <0.3 (ie a reduction to less than 30%) are significantly reduced ) In the 210 genes listed in Table 1, at least one tripling was observed at any of the time points in question

Among the 210 genes mentioned, as evidenced by Example 3, there are 67 genes with at least δ-fold induction at any of the observed time points under the conditions of the nitrogen deficiency described in Example 1. Of these, 18 may not be considered specific, so that, surprisingly, only those described in U.S. Pat These 49 genes are considered according to the invention as representative indicators of a nitrogen deficiency state Further information on these genes, for example on their function or deviating start codons are shown in Tables 2 and 3 and the sequence listing , the respective German-language names for the associated proteins have already been listed above, in the order of the statements in Table 3

The separately identified gene tnrA shows according to Example 5 30 min after the transition into the nitric acid-induced Staionarphase a more than 15-fold induction, so that this gene can be used to implement the teaching of the invention and is accordingly preferred

All these genes are individually described in the prior art. They can be found for the various organisms from generally accessible databases. As mentioned above, the sequences given in the Sequence Listing for B licheniformis DSM 13 are have been determined from this microorganism and are virtually identical to those described in the publication "The Complete Genome Sequence of Bacillus Licheniformis DSM13, to Organism with Great Industrial Potential" (2004) by B Veith et al in J Mol Microbiol Biotechnol, Vol. 7 (4), Pages 204 to 211, and additionally available under entry AE017333 (bases 1 to 4 222 645) in the database GenBank (see above). The strain S licheniformis DSM 13 is available from the German Collection of Microorganisms and Cell Cultures GmbH, Mascheroder Weg 1b, 38124 Braunschweig, Germany (http://www.dsmz.de/) Generally available at the American Type Culture Collection, 10801 University Boulevard, Manassas, VA 20110-2209, USA (http://www.cc.org/), the accession number ATCC 14580

The genes from other organisms corresponding to the abovementioned 50 genes are to a large extent likewise stored in generally accessible databases, for example for the well-characterized species B subtilis and E. coli, which are generally regarded as model organisms of gram-positive and / or gram-negative bacteria For example, the databases of the Institut Pasteur, 25.28 rue du Docteur Roux, 75724 Paris CEDEX 15, France, which are available on the Internet at http // genolist pasteur fr / Colibπ / (for E. coli), or http // Genolist pasteur fr / SubtιLιst / (for B subtilis) are accessible (as of 2 12 2004) Further suitable databases are those of the EMBL-European Biomformatics Institute (EBI) in Cambridge, Great Britain (http // www ebi ac uk), Swiss- Prot (Geneva Biomformatics (GeneBio) SA, Geneva, Switzerland, http://www.genebio.com/sprothtml) or GenBank (National Center for Biotec hnology Information NCBI, National Institutes of Health, Bethesda, MD, USA)

These "corresponding genes" are to be understood as those which each code for the proteins which catalyze the same chemical reaction in the organism under consideration or participate in the same physiological process as the said 50 proteins in B licheniformis DSM 13. Most of these carry for other organisms similar names and abbreviations as those given in Tables 1, 2 and 3 for ßlicheniformis, because these names stand for the respective function. In case of doubt they reveal themselves about their sequence, which from the respective organism to those to the here In the case of function assignment, the similarity of the amino acid sequences to one another is of particular importance because the amino acids represent the functional carriers of the protein and, because of the degeneracy of the genetic code, can code different nucleotide sequences for the same amino acid sequence

Particularly high degrees of kinship exist between closely related species. In principle, it can be assumed that homologues can be found in most species for most of the 50 genes mentioned, including in cyanobacteria, in eukaryotic cells such as fungi, or gram-negative species such as E. coli or Klebsiella. This is even more likely for Gram-positive bacteria, in particular the genus Bacillus, because it is a Bismemis DSM 13 from which the sequences listed in the Sequence Listing are such a Gram-positive bacterium It can be assumed that in increasingly related organisms, the homologous genes are increasingly subject to the same or equivalent regulatory mechanisms, so these homologs should also show the same metabolic situation, especially a nitrogen deficiency In this respect Blichemformis is a happily chosen example organism, because the commercially also particularly important species ß subtilis, B amyloliquefaciens, B lentus, B globigu are also bacilh and therefore gram-positive. This corresponds to the aspect of the task in question

It should be noted that not all of the abovementioned 50 genes must be known for working up the invention for a particular species, but only a few of them (see below) are sufficient to map the nitrogen metabolism and in particular to be able to detect the transition into a nitrogen deficiency state However, the reliability of the statement about the nitrogen supply state increases with increasing number of probes. If several genes, which in principle appear to be suitable based on the present disclosure, are known, it is advisable to carry out an expression study before producing a corresponding chip, similar to the representation in Example 1 or also Checking via a Northem analysis, whether the genes in question actually permit significant statements The less the species considered is related to Blichemformis, the more likely there will be shifts in the expression level caused by nitrogen deficiency that (possibly other than those compiled below) subgroups of these 50 genes are found to be particularly suitable and thus preferred

In the production of a nuclease acid-binding chip according to the invention for an organism not mentioned here, the associated homologous genes must therefore be identified for at least some of the genes mentioned for B lichemformis, for example by comparing the DNA sequences known for the organism concerned with those indicated here Sequences These or parts thereof (see below) can then serve as probes or as templates for the synthesis of corresponding probes, which are applied to a nucleic acid-binding chip by methods known per se

If individual homologous sequences are not stored in databases, it is possible for a person skilled in the art to synthesise respective probes on the basis of the sequences disclosed in the sequence listing for the present application, with the aid of which a gene bank prepared for the desired organism (genomically or preferably on the basis of the cDNA ) to search for the homologue in question using common methods. Alternatively, it is possible to synthesize, using the DNA sequences given in the Sequence Listing, oligonucleotides which serve as PCR primers to tag out the relevant genes or probes thereof from a whole genomic DNA preparation or a cDNA preparation of the organism of interest These or parts thereof (see below) can be used as probes on inventive nucleic acid-specific chips

An essential feature of the present invention is then that the total number of different nitrogen metabolism-specific different probes does not exceed 80. This feature correlates with the stated task, according to which it should focus on such nucleic acid-binding chips, their number of assignable bursts due to their Type is comparatively low These are in particular the electrically analyzable chips

Among the other nitrogen-specific-change-specific probes may be, for example, those that are induced by a nitrogen excess, possibly also others that are apparently not directly related to the nitrogen metabolism, but due to this inducibility can be defined as such Thus, such a chip also gives a evaluable and useful in the process considered information when the lack of nitrogen, for example, has been overcome by taking appropriate countermeasures

In addition, nucleic acid-specific probes are usually only fragments of the complete genes (see below). In individual cases, for example in the case of regulation via splicing or large, multi-functional polypeptides, it may therefore be useful to use one and the same gene with two or more Thus, corresponding embodiments may be characterized by more than 50 probes which, however, respond to no more than these 50 genes

Depending on the process to be observed, probes for further genes or gene products can also be contained on chips according to the invention (see below).

On the other hand, the core of the invention lies precisely in the specificity of the particular chip with which a specific metabolic situation should be detected. The production of a chip with more than 80 probes responding to different genes or even a chip which represents a large part of the genome of an organism. Rather, both types of chips can be usefully used side by side in an observed bioprocess. Thus, the chips can be used with numerous different probes or with a representative cross section of various potentially relevant situations, such as they are provided with the application WO 2004/027092 A2, a rough overview about the state of the organism in question while a chip according to the invention is consulted for control when there is a concern that the cells in question may enter a nitrogen deficiency state

In a preferred embodiment, it is a nucleic acid-binding chip according to the invention, which is increasingly preferably doped with the probes specified above in the order given there

Thus, the genes listed in Table 3 are meant in reverse order Accordingly, chips with probes to gene kdgR (transcriptional repressor of the pectin degradation operon, SEQ ID NO 25, 26) among the chips according to the invention are still least in terms of gene selection for the formation of probes In contrast, those with a probe for the gene coding for a hypothetical protein of unknown function (homologue to SEQ ID NO. 81, 82) are inferior in terms of the Genome selection most preferred Because this showed over the initial level of a more than 146-fold induction and thus the strongest of all genes measured The signal associated with this should therefore be of all genes best suited to indicate the metabolic situation "nitrogen deficiency"

TnrA lies between trpC and trpB according to example 5 and is accordingly preferred

In a preferred embodiment, it is a nucleic acid-binding chip according to the invention, wherein at least one, more preferably two or three of the probes are selected from the following 34 genes / are genes coding for a conserved hypothetical protein of unknown function (homologue to SEQ ID NO 19), for a putative protein (ATP Bιndungsproteιn a putative ABC transporter) encoding gene (homologue to SEQ ID NO 55), ycnJ, glnR, yvIA, yncE, yvlB, for a putative protein (putative hydrolase) encoding gene (homolog to SEQ ID NO 47), trpF, ydfS, trpD, gene coding for a putative protein (putative phage capsid protein) (homologue to SEQ ID NO 21), ycnK, trpB, trpC, for a putative protein (putative transcription protein). Regulator) (homologue to SEQ ID NO 17), coding for a putative protein (putative sennprotease) encoding gene (homologue to SEQ ID NO 9), for a putative protein (putative glycosylhydrolase / lysozyme) of the gene (homolog to SEQ ID NO 85), for a putative protein (putative malate synthase, EC 4 1 3 2) coding gene (homolog to SEQ ID NO 45), for a putative protein (putative Na (+) - linked D- Alanine glycine permease) (homologue to SEQ ID NO 49), gene coding for a hypothetical protein of unknown function (homologue to SEQ ID NO 95), nasD, for a putative protein (putative ammonium Transporter) (homologue to SEQ ID NO 63), ycdH, nasC, for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) encoding gene (homolog to SEQ ID NO 15), nasB, trpE, pckA, for a putative Protein (putative nitrogen regulatory protein P-II) encoding gene (homologue to SEQ ID NO 93), nasF, yrkC, gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO 81), tnrA

Because these genes showed in the examples carried out in the examples by B licheniformis DSM 13, shown in Examples 1 to 3 and 5 gene inductions, which were at least increased by a factor of 10. Accordingly, preferred embodiments are characterized by the first 33 of Table 3 labeled genes

Further preferred are such nucleic acid-binding chips according to the invention, wherein at least one, more preferably two or three of the probes are / are selected from the following 20 genes

UpC, gene coding for a putative protein (putative transcriptional regulator) (homologue to SEQ ID NO 17), gene coding for a putative protein (homologous to SEQ ID NO 9), for a putative protein (putative glycosylhydrolase / Lysozyme) gene (homologue to SEQ ID NO 85), for a putative protein (putative malate synthase, EC 4 1 3 2) encoding gene (homologue to SEQ ID NO 45), for a putative protein (putative Na (+) - linked D-alanine glycine permease) (homologue to SEQ ID NO 49), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO 95), nasD, gene coding for a putative protein (putative ammonium transporter) (homolog to SEQ ID NO 63), ycdH, nasC, gene encoding a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) (homologue to SEQ ID NO 15), nasB, trpE, pckA, for a putative protein (putative nitrogen regulatory protein P-II) coding gene (Hom olog to SEQ ID NO 93), nasF, yrkC, gene coding for a hypothetical protein of unknown function (homologue to SEQ ID NO 81), tnrA

For these genes showed gene inductions, which were increased by at least a factor of 15, in the tests carried out in the examples on the basis of S licheniformis DSM 13 and illustrated in Examples 1 to 3 and 5

Further preferred are nucleic acid-binding chips according to the invention, wherein at least one, more preferably two or three of the probes are selected from the following 12 genes / nasD, gene coding for a putative protein (putative ammonium transporter) (homologue to SEQ ID NO 63), ycdH, nasC, gene encoding a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) (homologue to SEQ ID NO 15), nasB, trpE, pckA putative protein (putative nitrogen regulatory protein P-II) encoding gene (homologue to SEQ ID NO 93), nasF, yrkC, gene coding for a hypothetical protein of unknown function (homologue to SEQ ID NO 81)

Because these genes showed in the examples carried out in the examples using B lichemformis DSM 13, shown in Examples 1 to 3 investigations gene inductions that were increased by at least a factor of 20

Further preferred are such nucleic acid-binding chips according to the invention, wherein at least one, increasingly preferably two or three of the probes are selected from the following 4 genes / are genes coding for a putative protein (putative nitrogen regulatory protein P-II) (homolog to SEQ ID NO 93), nasF, yrkC, gene coding for a hypothetical protein of unknown function (homologue to SEQ ID NO 81)

For these showed in the examples carried out in the examples by S lichemformis DSM 13, shown in Examples 1 to 3 gene inductions, at least by a factor of 30, in the case of yrkC by more than 60 and in the latter case even significantly more than were increased by a factor of 100

In preferred embodiments, nucleic acid-binding chips according to the invention with at least 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 22, 24, 26 28, 30, 35, 40, 45 or 50 doped for the present invention, that is, in this sense called probes doped

For the more of these probes respond to a corresponding signal, the more reliable is the associated statement about the instantaneous supply or supply of nitrogen. Thus, it makes sense to combine the particularly meaningful and therefore preferred embodiments with apparently less meaningful probes in order to avoid false positives. Furthermore, it is advantageous to combine such probes with one another according to the information given in Table 2, which give signals of different strengths at different times indicated there. Thus, it is possible to arrive at an estimate as to how long before sampling the occurrence of the nitrogen deficiency may be due to a specific environmental impact, with a record of cultivation conditions

With regard to their specific sequences, different probes which, however, respond to the same mRNA, for example fragments which hybridize with different regions of the same mRNA (see below), may be represented several times to increase read-out certainty. However, in the sense of this aspect of the invention, they are counted only once because, in the best case, they respond equally to the same signal and, in principle, would be interchangeable with one another

In preferred embodiments of nucleic acid chips according to the invention, the total number of all different probes is increasingly preferably not more than 80, 75, 70, 65, 60, 55, 50, 40, 30, 20 or 10

This corresponds to the inventive idea outlined above, according to which a special metabolic aspect is to be monitored with the chips described here, so that a larger number of probes than necessary for detecting this situation need not be applied to the relevant chips. The situation remains unaffected in individual cases, it may be useful to use more than one probe for the detection of the same mRNA and / or apply individual probes that are associated with the production of a valuable material of interest. Overall, the present invention moves in the said frame to chips for technical reasons only a few Binding sites in the scope to include

In preferred embodiments of nucleic acid-binding chips according to the invention, the probes referred to as being relevant to the invention are those which respond to the relevant or most highly homologous, in vivo transcribable genes from the organism selected for the bioprocess, preferably those from the relevant or most highly homologous , In vivo transcπbierbaren genes are derived just this organism

For this purpose, it has already been stated above that the sequences of B licheniformis disclosed in the present application were obtained and, owing to the generally known relationships, in particular should be suitable for monitoring related species, in particular those of the genus Bacillus. This applies both to the identified genes, to whom specific functions could be assigned on the basis of database comparisons and which should in principle code for the same function in other species, as well as for those who have been defined only by their sequences. According to the invention, the genes closely related in the organism in question are used to derive corresponding probes However, to ensure that no probes are generated to pseudogenes, but to those that are actually rewritten under / n-two Bedιngungen in mRNA, that is, which lead to a measurable in the cytoplasmic nucleic acid signal

Statistically, however, such a chip should be all the more successful, the better the selected probes mute with the nucleic acids to be measured. Thus, especially with decreasing degree of relatedness to B licheniformis, the necessity of relying on the sequences given in this hybridization does not increase - if the sequence As explained above, these can be determined by methods known per se, in particular gene bank screening or PCR with primers oriented on the sequences disclosed here (optionally in the form of so-called mismatch polymers with certain amino acids) , statistical sequence variations)

In preferred embodiments of nucleic acid-binding chips according to the invention, the organism selected for the bioprocess is a representative of unicellular eukaryotes, Gram-positive or Gram-negative bacteria

Because in these groups fall the most commercially used organisms, especially when it comes to the observed bioprocess is a fermentation This includes, for example, cooking processes, such as the production of wine or beer, or the biotechnological production of valuable substances such as proteins or low molecular weight compounds

Depending on the type of product desired, various organisms are chosen for a biotechnological process. For the purposes of the invention, these are to be understood as meaning not only the production strains but also all organisms preceding the production process, for example for cloning corresponding genes or selecting suitable expression vectors In this case, there is a partial limitation during each sub-process

In preferred embodiments of inventive nucleic acid-binding chips, the unicellular eukaryotes are protozoa or fungi, including in particular yeast, very particularly Saccharomyces or Schizosaccharomyces

Because these are in addition to the production of alcoholic beverages and other foods obtained by cooking intensively used as host cells in particular for the gene products of eukaryotes. The latter is particularly advantageous if these gene products are to undergo special, durchfuhrbare only by these strains modifications, such as glycosylations of proteins

This object also includes chips according to the invention, which are directed to the monitoring of the course, in particular the growth of cell cultures of higher eukaryotes, such as rodents or humans They can be understood in some respects as at least largely single-celled eukaryotes, in particular in the Immunology have significant commercial importance, for example for the production of monoclonal antibodies In preferred embodiments of nucleic acid-binding chips according to the invention, the gram-positive bacteria are Coryneform bacteria or those of the genera Staphylococcus, Corynebacteria or Bacillus, in particular the species Staphylococcus carnosus, Corynebacterium glutamicum, Bacillus subtilis, B licheniformis, B amyloliquefaciens, B agaradherens, B stearothermophilus, B globign or lentus, and especially B licheniformis

Because these are technically particularly important production strains They are used in particular for the production of low molecular weight chemical compounds, such as vitamins or antibiotics or for the production of proteins, in particular enzymes Here are particularly amylases, cellulases, lipases, oxidoreductases and proteases particularly noteworthy The special focus on B licheniformis is explained by the fact that the sequences given in the sequence listing were obtained from this species and could be demonstrably linked to the transition into a nitrogen deficiency as described in Examples 2 and 3

In no less preferred embodiments of nucleic acid-binding chips according to the invention, the gram-negative bacteria are those of the genera E. coli or Klebsiella, in particular derivatives of Escherichia coli K12, Escherichia coli B or Klebsiella planticola, and more particularly derivatives of the strains Escherichia coli BL21 (DE3), E. coli RV308, E. coli DH5α, E. coli JM109, E. coli XL-1 or Klebsiella planticola (Rf)

Because these serve both on a laboratory scale, for example, the cloning and expression analysis as well as on a large scale of the production of biological valuable materials

In preferred embodiments of nucleic acid-binding chips according to the invention, at least one, more preferably more, of the probes mentioned in connection with the invention described herein are / derived from the sequences which are listed in the Sequence Listing under the numbers SEQ ID NO 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97 and 99 are listed

Because these genes could, as described in Examples 2 and 3, in S licheniformis demonstrably associated with the transition to a nitrogen deficiency In particular, if B licheniformis or other, especially related Bacillus species are to be monitored, should therefore on these sequences be resorted to Preferred embodiments of nucleic acid-binding chips according to the invention are those which are additionally doped with at least one probe for an additional gene, in particular one which is in a metabolic-related relationship to the process-related additionally-expired gene (s) , especially for one of them or this one

As noted above, the processes under observation serve a technical interest, often associated with other specific genes. For example, in the case where a protein is to be produced, the gene for that protein and, in the case of a low molecular weight compound It is also possible to affect other cell-specific genes, such as metabolic genes, which must be increasingly formed during the production of the product, for example a cell-derived oxidoreductase, if this is to be produced Product should be obtained from a reactant or an intermediate via oxidation or reduction

In addition, for certain biological processes, in particular the formation of commercially relevant compounds by microorganisms usually not the wild-type strains are used, but those that are geared to the process in question This includes the transformation with the responsible for the actual product manufacturing genes oversight with selection markers or further adaptations of the metabolism, up to auxotrophies Such strains have a special demand profile on the growth conditions and partly have metabolic genes that are mutated compared to the wild-type genes. Since erfmdungsmäße chips advantageously aligned to just these strains, especially the considered bioprocess should be taken into account, these strain-specific peculiarities and may be reflected in the choice of the probes concerned

In preferred embodiments of such nucleic acid-binding chips according to the invention, the gene additionally expanded by the process is that for a commercially useful protein, in particular an amylase, cellulase, lipase, oxidoreductase, a hemicellulase or protease, or one which has a synthesis route for a low molecular weight chemical compound or at least partially regulated

These are then particularly geared to those bioprocesses, especially fermentations, in which the said proteins are produced. These are commercially particularly important enzymes which are used, for example, in the food industry or the detergent industry. In the latter case, in particular for the removal of Soils caused by amylases, cellulases, lipases, hemicellulases and / or proteases are hydrolyzable, for the treatment of the materials in question, in particular by cellulases or to provide an oxidative based on an oxidative enzymatic bleaching system

The latter variant falls within the field of biotransformation, according to which certain, optionally additionally introduced metabolic activities of microorganisms for the synthesis of chemical compounds are exploited

In preferred embodiments of nucleic acid-binding chips according to the invention, one, preferably several, of the probes mentioned in connection with the invention described here is / are provided in single-stranded form in the form of the codogenic strand

This embodiment has the aim to improve the hybridization between the probe and the sample to be detected. This is especially true in the case where the content of the relevant mRNA is actually determined from the sample because it is single-stranded and in its sequence with the coding strand the DNA matches, should an optimal hybridization with the complementary, that is the codogenic strand done

In preferred embodiments of nucleic acid-binding chips according to the invention, one, preferably several, of the probes called relevant to the invention in the form of a DNA or of a nucleic acid analog, preferably of a nucleic acid analog, is / are made available

This requirement is aimed at improving the durability and repeated usability of the chips according to the invention. This need arises in particular during a single observed process in the course of which constant monitoring is desirable. The durability of chips according to the invention, in particular with respect to nucleic acid-hydrolyzing enzymes, is already demonstrated by the Providing the probes in the form of a DNA increased, since this is less susceptible to hydrolysis than about an RNA Nucleic acid analogs are even more durable, in which, for example, the phosphate of Zucker-phosphate backbone is replaced by a chemically different building block, which is not hydrolyzed by natural nucleases Such compounds are known in principle in the art and are commercially synthesized for desired sequences to be specified by companies specialized in this field if desired. The relevant probes are to synthesize, for example, on the model of the sequences given in the Sequence Listing

In preferred embodiments, nucleic acid-binding chips according to the invention comprise / comprise one, preferably several, of the probes called relevant to the invention Gene regions which are transcribed into mRNA by the organism to be examined, in particular the gene regions which are close to the 5 'end of the mRNA

Hereby, the aspect is taken into account that in many cases the regulatory DNA segments are also assigned to a specific gene. In fact, however, the chip according to the invention should be used to detect the mRNA actually present in the observed cells, so that for the purpose considered here the first On the other hand, it should be noted that, in particular in eukaryotes introns occur, that is, the coding region is interrupted by sections that are not translated into mRNA Probes containing introns, therefore, were not allowed or In order to realize this aspect, it is advisable not to resort to genomic DNA sequences but to cDNA sequences, that is, those obtained from the actual mRNA

Furthermore, hybridization is often not necessary for the detection of an mRNA over the entire length of time. Therefore, the specific probes generally only need to comprise a smaller of the gene transcribed into mRNA. A selection of a region close to the 5 'end is advantageous for this purpose the mRNA is located, as it is first transcribed into mRNA and thus is the first to be detected after activation of the gene. This precludes timely detection

In preferred embodiments of nucleic acid-binding chips according to the invention, one or more of the probes called relevant to the invention are / are responsive to fragments of the relevant nucleic acids, in particular to those which have a low degree of secondary folding in the relevant mRNA, based on the respective total mRNA

This is another aspect of optimizing the hybridization between the probes and the mRNA to be detected because mRNA molecules often have a secondary structure that is based on hybridization of individual mRNA regions with their own, other regions. or Stem Ioop Structures Such regions, however, tend to hybridize less readily to other nucleic acid molecules, even if they are homologous. Such regions can be calculated quite accurately from computer programs directed thereto (see below). Thus, to realize this aspect, one should consider the gene whose To determine the activity of interest to an organism of interest, let such a program analyze it and, in order to obtain a suitable - usually only a subset (see below) probe - refer to sections for which only a low level of mRNA secondary structures is predicted In preferred embodiments of nucleic acid-binding chips according to the invention, one, preferably several, of the probes called relevant to the invention has a length of increasingly preferably less than 200, 150, 125 or 100 nucleotides, preferably from 20 to 60 nucleotides, particularly preferably from 45 to 55 nucleotides on

Because the probes used for the detection reaction need only to include parts of the mRNA to be detected, if the signal available on them is still specific enough This specificity, the distinctness of different mRNA sets the lower limit for the length of the respective probes and must be experimentally if necessary in preliminary experiments be determined

The identification of suitable probes with respect to their length and each appropriate ranges, is known to those skilled in the art and is usually with the help of specialized software performed Examples of such software are the array program designer of the FA Premier Biosoft International, USA, and Vector NTI ^® Suite, V 7, available from InforMax, Ine, Bethesda, USA, a newer version of this program is distributed by Invitrogen, Carlsbad, CA, USA. In addition to the secondary structures already mentioned, these software programs also take into account given lengths of probe as well melting temperatures

In preferred embodiments of nucleic acid-binding chips according to the invention, an electrical signal is triggered by the binding of the mRNA to the probe in question as being relevant to the invention

In the already mentioned article J Wang (Acc Chem Res, ISSN 0001-4842, Rec Sept 12, 2001, S AF) the advantages of an electrically evaluable system over an optical system are discussed. Further, various embodiments of such sensors developed in the prior art are discussed directed

Thus, at the present time, the time from sampling to measuring the signal for optically analyzable chips is approximately 24 hours. Using an electrical system, the time required is currently less than 2 hours (see Figure 1). On the other hand, the number of simultaneously analyzable samples is electrical evaluable chips currently in the double-digit range, but a rapid development suggests that this magnitude can be exceeded in Briefly limiting the electronic evaluation units for the various signals

A method for mRNA quantification established in the prior art is, for example, the RT-PCT. This is described in the article "Quantification of Bacteπal mRNA by One-Step RT-PCR Using the LightCycler System "(2003) by S Tobisch, T Koburger, B Jürgen, S Leja, M Hecker and T Schweder in BIOCHEMICA, Volume 3, pages 5 to 8 In contrast, the detection of electrical chips has another advantage, namely the higher reliability of the data, since these have significantly lower fluctuation ranges compared to RT-PCR

The production of corresponding electronically evaluable chips is described, for example, in the patent applications WO 00/62048 A2, WO 00/67026 A1 and WO 02/41992, the disclosure content of which is fully incorporated into the present application

The mode of operation of electrically readable chips of a particularly preferred embodiment can be described as follows: The gene-specific probes are covalently bound to magnetic carriers (beads) in known manner, which are located in chambers of the chips provided for this purpose. The specific hybridization of the corresponding mRNA to the respective mRNA The beads are held in this chamber by a magnet. After the hybridization of the RNA samples to the bead-bound DNA probes, a washing step is carried out to eliminate the non-beaded DNA probes. bound RNA, so that in the incubation only specific hybrids are still present, bound to the magnetic beads

After washing, a detection probe is introduced into the incubation chamber labeled with a biotin extravidin-linked alkaline phosphatase. This probe binds to a second free region of the hybridized mRNA. This hybrid is then washed again and with the alkaline phosphatase substrate para-aminophenol phosphate (pAPP) incubated The enzymatic reaction in the incubation chamber leads to the release of the redox-active product para-aminophenol (pAP) This is now passed over the Red / Ox electrode on the electrical chip and sent the signal to a potentiostat

System-specific software (eg, MCDDE32) reads the data obtained, and the results can be evaluated and displayed on another computer using another program (for example, Origin)

Of course, this process can be varied both with regard to the technical design of the chips and the evaluation. For example, the detection reaction can also be carried out by another, but preferably a redox reaction because of the electrical measurement principle

It is an object of the present invention to identify nitrogen metabolism-specific genes that are critical for the process and to make them accessible to the analysis via correspondingly designed biochips. The Advantage of Chips Compared to Conventional Detection Methods in addition to gaining time and higher accuracy, then, by providing multiple probes on one carrier simultaneously in the same sample, the activities of several different genes can be detected and, in the application described herein, to a more specific problem can give a more solid and detailed picture for example, the time at which a nitrogen deficiency occurred

A separate subject of the invention is thus the simultaneous use of nucleic acid or nucleic acid analog probes for at least three of the following genes kdgR, citA, for a putative protein (putative ABC transporter / amino acid permease) encoding gene (homolog to SEQ ID NO 91), htrA, ycnI, gene coding for a hypothetical protein of unknown function (homologue to SEQ ID NO 41), gene coding for a hypothetical protein of unknown function (homologue to SEQ ID NO 53), yppF, yqjN, ggt, as R, glnA, nrgA, yαC, yvtA, nrgB, gene encoding a conserved hypothetical protein of unknown function (homologue to SEQ ID NO 19), gene coding for a putative protein (ATP digestion protein of a putative ABC transporter) (homologue to SEQ ID NO 55), ycnJ, glnR, yvIA, yncE, yvlB, for a putative protein (putative hydrolase) encoding gene (homologue to SEQ ID NO 47), trpF, ydfS, trpD, for a putative protein (putative phage capsid protein) codi gene (homolog to SEQ ID NO 21), ycnK, trpB, trpC, gene coding for a putative protein (putative transcription regulator) (homologue to SEQ ID NO 17), gene coding for a putative protein (homolog to SEQ ID NO 9), for a putative protein (putative glycosyl hydrolase / lysozyme) encoding gene (homologue to SEQ ID NO 85), for a putative protein (putative malate synthase, EC 4 1 3 2) coding gene (homologue to SEQ ID NO 45), gene encoding a putative protein (putative Na (+) - linked D-alanine glycine permease) (homologue to SEQ ID NO 49), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO 95), nasD , gene coding for a putative protein (putative ammonium transporter) (homologue to SEQ ID NO 63), ycdH, nasC, gene coding for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) (homologue to SEQ ID NO 15), nasB, trpE, pckA, for a putative protein (putatives stick substance regulation protein P-II) gene (homologue to SEQ ID NO 93), nasF, yrkC, gene coding for a hypothetical protein of unknown function (homologue to SEQ ID NO 81), tnrA bound to a nucleic acid-binding chip, preferably to the same, to determine the physiological state of a biological process going through an organism

As explained above, these genes are selected so as to give an idea of the situation of the nitrogen metabolism of the organism under consideration, because they are as described in Examples 1 to 3 and 5 in the transition of the gram-positive bacterium to the nitrogen-deficient state be induced significantly and comparatively specifically Statements are to be expected also for other organisms, which have the homologous genes or proteins with essentially the same metabolically relevant properties

As already described in detail, such gene activities can in principle be determined in various ways, for example by Northem hybridization. The analysis using a nucleic acid-binding chip, in particular one described above, however, opens up the possibility of very efficiently determining several gene activities in a very efficient manner In addition, this very timely Thus, the metabolic changes of an organism, which undergoes a biological process, observed in a timely manner and, if necessary, intervene regulatory

The statements made above on nucleic acid-binding chips apply correspondingly to the uses of the probes described here

Accordingly, these are preferably such uses, with the total number of all nitrogen-specific, different probes not exceeding 80

Accordingly, these are also preferably uses where the probes previously indicated as being in accordance with the invention are increasingly preferably used in the sequence previously indicated as preferred (inversely to the order in Table 3, including Example 5)

In accordance with the above statements, the following uses of nucleic acid or nucleic acid analogue probes are increasingly preferred - use, wherein at least one, more preferably two or three, of the nucleic acid or nucleic acid analogue probes for genes from the following 34 genes is / are specific for a conserved hypothetical protein of unknown function gene (homologue to SEQ ID NO 19), for a putative protein (ATP Bιndungsproteιn a putative ABC T ranspor- ters) coding gene (homologue to SEQ ID NO 55), ycnJ, glnR, yvIA, yncE, yvlB, for a putative protein (putative hydrolase) encoding gene (homologue to SEQ ID NO 47), trpF, ydfS, trpD, for a putative protein (putative phage capsid protein) encoding gene ( Homolog to SEQ ID NO 21), ycnK, trpB, trpC, gene coding for a putative protein (putative transcription regulator) (homologue to SEQ ID NO 17), for a putative protein (putative secretin otease) gene encoding (homolog to SEQ ID NO 9), for a putative protein (putative glycosyl hydrolase / lysozyme) encoding gene (homologue to SEQ ID NO 85), for a putative protein (putative malate synthase, EC 4 1 3 2) coding gene (Homologue to SEQ ID NO 45), gene encoding a putative protein (putative Na (+) - linked D-alanine glycine permease) (homologue to SEQ ID NO 49), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO 95), nasD, for a putative protein (putative ammonium transporter) encoding gene (homolog to SEQ ID NO. 63), ycdH, nasC, for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) encoding gene (homologue to SEQ ID NO. 15), nasB, trpE, pckA, gene encoding a putative protein (putative nitrogen regulatory protein P-II) (homologue to SEQ ID NO: 93), nasF, yrkC, gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO. 81), tnrA;

- Of these, preferably for genes from the following 20 genes: trpC, for a putative protein (putative transcriptional regulator) encoding gene (homologue to SEQ ID NO. 17), for a putative protein (putative serine protease) coding gene (homolog to SEQ ID NO 9), a gene coding for a putative protein (putative glycosyl hydrolase / lysozyme) (homologue to SEQ ID NO: 85), gene coding for a putative protein (putative malate synthase, EC 4.1.3.2) (homologue to SEQ ID NO ) gene encoding a putative protein (putative Na (+) - linked D-alanine-glycine permease) (homologue to SEQ ID NO: 49), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 95), nasD, gene encoding a putative protein (putative ammonium transporter) (homologue to SEQ ID NO: 63), ycdH, nasC, gene coding for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) (homologue to SEQ ID NO. 15), nasB, trpE, pckA, for a putative protein n (putative nitrogen regulatory protein P-II) coding gene (homolog to SEQ ID NO. 93), nasF, yrkC, gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 81), tnrA;

particularly preferred for genes from the following 12 genes: nasD, for a putative protein (putative ammonium transporter) coding gene (homologue to SEQ ID NO. 63), ycdH, nasC, for a hypothetical protein (close homolog to aldehyde DhaSha gene encoding gene (homologue to SEQ ID NO: 15), nasB, trpE, pckA, gene coding for a putative protein (putative nitrogen regulatory protein P-II) (homologue to SEQ ID NO: 93), nasF, yrkC, gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 81);

Of these, very particularly preferred for genes from the following 4 genes: gene encoding a putative protein (putative nitrogen regulatory protein P-II) (homologue to SEQ ID NO: 93), nasF, yrkC, gene coding for a hypothetical protein of unknown function (Homologue to SEQ ID NO. 81).

In accordance with the above, they are preferably uses according to the invention of simultaneously at least 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 35, 40 , 45 or 50 of said probes. In accordance with the above, they are preferably uses according to the invention, wherein the total number of all different probes is increasingly preferably not more than 80, 75, 70, 65, 60, 55, 50, 40, 30, 20 or 10

According to the above, it is furthermore preferable to use according to the invention for determining a change in the nitrogen metabolism of the organism passing through the biological process, preferably for the detection of a nitrogen deficiency state

In accordance with the above, furthermore, it is preferable to use according to the invention, wherein at least one, more preferably more of said probes are derived from the sequences which are listed in the sequence listing under the numbers SEQ ID NO 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97 and 99 are listed

A separate subject of the invention are methods of determining the physiological state of an organism passing through a biological process by using a nucleic acid-binding chip according to the invention

These methods look in principle such that during the process and without interrupting him, samples of the observed organism removed and the mRNA are isolated from these These or optionally derived therefrom compounds such as cDNA are passed over a nucleic acid-binding chip described above, which under Considering the above-mentioned process steps - such as sufficient incubation time or washing off non-specifically binding nucleic acids - treated and finally fed to the detection device Such a process protocol is illustrated in principle with reference to the example of electrically evaluable chips in Figure 1

The statements made above regarding nucleic acid-binding chips apply correspondingly to the method of determining the physiological state of an organism passing through a biological process

Preferably, it is process according to the invention, wherein a change in the nitrogen metabolism of the organism passing through the biological process is determined, preferably a nitrogen deficiency state

Because with respect to this application, the genes described in the examples and listed above have been selected their significant induction is at least in B licheniformis associated with the occurrence of a nitrogen deficiency state, so that this with the These processes can be detected particularly reliably, and not only in S Likemformis but also with increasingly better prospects for increasingly related species (see above) In addition, this metabolic situation in the life cycle of many microorganisms is a critical date So was in the examples examined (see below A transition into the stationary growth phase is always associated with the respective occurrence of the nitrogen deficiency. Processes which help to recognize this point in time serve to delay this transition and, especially in the case of large-scale fermentations, prolong the phase of production of a valuable substance, especially if it is a nitrogenous recyclable such as a protein

Another possibility of the procedure in the cultivation of microorganisms is then, in addition to the first (and therefore better) used N source to provide another in the phase of the first observed nitrogen deficiency, the cells concerned, if they are able to are, on the use of the second, for them less usable N-source with this transition is usually observed a delay in growth, which can be detected early on a process according to the invention

According to the above, such methods according to the invention are preferred, wherein the organism selected for the bioprocess is a representative of unicellular eukaryotes, Gram-positive or Gram-negative bacteria

According to the above, such methods according to the invention are preferred among them, wherein the unicellular eukaryotes are protozoa or fungi, including in particular yeast, especially Saccharomyces or Schizosaccharomyces

According to the above, such methods according to the invention are also preferred, the gram-positive bacteria being Coryneform bacteria or those of the genera Staphylococcus, Corynebacteria or Bacillus, in particular the species Staphylococcus carnosus, Corynebacterium glutamicum, Bacillus subtilis, B lichemformis, B amyloliquefaciens , B agaradherens, B stearothermophilus, B globign or Lentus, and especially B lichenemis

According to the above, such methods according to the invention are no less preferred, the Gram-negative bacteria being those of the genera E. coli or Klebsiella, in particular derivatives of Escherichia coli K12, Escherichia coli B or Klebsiella planticola, and more particularly derivatives of strains Escherichia coli BL21 (DE3), E. coli RV308, E. coli DH5α, E. coli JM109, E. coli XL-1 or Klebsiella planticola (Rf) In accordance with the above, such methods according to the invention are preferred, using those of the named probes which are of the SEQ ID NO. 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21 given in the sequence listing. 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97 or 99 are derived

Of these, in turn, those methods are preferred in which the probes mentioned here are used for the Gram-positive bacteria listed above, in particular Blichemformis, since these sequences have been isolated from this same organism and thus can be applied most successfully to these species

According to the above, such methods according to the invention are preferred, wherein the determination of the physiological state is carried out at different points in time of the same process, preferably using a plurality of identically constructed nucleic acid-binding chips, particularly preferably the same nucleic acid-binding chip

In accordance with the above, such processes according to the invention are furthermore preferred, the process being a fermentation, in particular the fermentative production of a commercially useful product, more preferably the production of a protein or a low-molecular chemical compound

According to the above, such methods according to the invention are preferred, wherein the low-molecular chemical compound is a natural substance, a food supplement or a pharmaceutically relevant compound

In accordance with the above, such methods according to the invention are alternatively preferred, wherein the protein is an enzyme, in particular one of the group of α-amylases, proteases, cellulases, lipases, oxidoreductases, peroxidases, laccases, oxidases and hemicellulases

An independent subject of the invention is also the possible uses of nucleic acid-binding chips according to the invention, as described in detail above, for determining the physiological state of an organism passing through a biological process

The statements made above on nucleic acid-binding chips apply correspondingly to the uses described herein for the determination of the physiological state of an organism passing through a biological process According to the above, such uses according to the invention are preferred, wherein a change in nitrogen metabolism of the organism passing through the biological process is determined, preferably a nitrogen deficiency state

According to the above, such uses according to the invention are furthermore preferred, wherein the organism selected for the bioprocess is a representative of unicellular eukaryotes, Gram-positive or Gram-negative bacteria

According to the above, such uses according to the invention are preferred, the unicellular eukaryotes being protozoa or fungi, in particular yeast, especially Saccharomyces or Schizosaccharomyces

According to the above, alternative uses according to the invention are no less preferred, the Gram-positive bacteria being Coryneform bacteria or those of the genera Staphylococcus, Corynebacteria or Bacillus, in particular the species Staphylococcus carnosus, Corynebacterium glutamicum, Bacillus subtilis, B licheniformis, B amyloliquefaciens, B agaradherens, B stearothermophilus, B globign or B lentus, and especially B licheniformis

According to the above, such uses according to the invention are no less preferred, the Gram-negative bacteria being those of the genera E. coli or Klebsiella, in particular derivatives of Escherichia coli K12, Escherichia coli B or Klebsiella planticola, and more particularly derivatives strains Escherichia coli BL21 (DE3), E. coli RV308, E. coli DH5α, E. coli JM109, E. coli XL-1 or Klebsiella planticola (Rf)

In accordance with the above, such uses according to the invention are preferred, using those of said probes which are of the SEQ ID Nos. 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, listed in the Sequence Listing, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97 or 99 are derived

Among these, again, for the reason already mentioned, those uses are preferred in which the probes mentioned here are used for the previously mentioned Gram-positive bacteria, in particular B licheniformis

According to the above, such uses according to the invention are preferred, wherein the determination of the physiological state at different times thereof Process is carried out, preferably using a plurality of identical nucleic acid bmdender the chips, particularly preferably the same nucleic acid-binding chip

According to the above, such uses according to the invention are furthermore preferred, the process being a fermentation, in particular the fermentative production of a commercially useful product, more preferably the production of a protein or a low-molecular chemical compound

According to the above, such uses according to the invention are preferred, wherein the low-molecular chemical compound is a natural substance, a food supplement or a pharmaceutically relevant compound

According to the above, such uses according to the invention are alternatively preferred, wherein the protein is an enzyme, in particular one from the group of α-amylases, proteases, cellulases, lipases, oxidoreductases, peroxidases, laccases, oxidases and hemicellulases

The present invention is further illustrated by the following examples

Examples

All molecular biology procedures are followed by standard methods such as those described in the Handbook of Fπtsch, Sambrook and Maniatis "Molecular Clonmg a laboratory manual", CoId Spring Harbor Laboratory Press, New York, 1989, or comparable pertinent art used according to the specifications of the respective manufacturer

Example 1: Identification of the gene probes by chip analyzes

Cultivation of bacteria and sample collection

Cells of the strain Bacillus hcheniformis DSM13 (available from the German Collection of Microorganisms and Cell Cultures GmbH, Mascheroder Weg 1b, 38124 Braunschweig, Germany, http://www.dsmz.de) were grown in nitrogen-primed, synthetic Belitsky minimal medium (1 mM final concentration) at 37 ° C cultivated under constant debris at 270 rpm This medium has the following composition (1) base medium (pH 7.5) 0.015 M (NH ₄ J ₂ SO ₄ , 0.008 M MgSO ₄ .7H ₂ O, 0.027 M KCl, 0.007 M Na ₃ citrate x 2H ₂ O ₁ 0.050 M Tπs-HCl and 0.009 M glutamic acid, (2) supplements 0.2 M KH ₂ PO ₄ , 0.039 M L-tryptophan HCl, 1 M CaCl ₂ x 2H ₂ O, 0.0005 M FeSO ₄ × 7H ₂ O, 0.025 M MnSO ₄ × 4H ₂ O and 20% (w / v) glucose, and as (3) medium supplementation scheme 0.14 ml KH ₂ PO ₄ , 0.2 ml CaCl ₂ , 0, 2 ml FeSO ₄ , 0.04 ml MnSO ₄ , 1 ml glucose All values are based on 100 ml of basic medium

In the course of the growth curve, at an optical density of 500 nm (OD ₅₀ o) of 0.4 to 0.5, the control sample and in the transient growth _phase at an OD _50O of 0.8 to 0.9 another sample ("transition The above-mentioned supplementation scheme for the Belitzky minimal medium is adjusted so that from an OD _50O of 0.8 to 1, 0 nitrogen deficiency occurs and thus the stationary phase is initiated Further sampling took place after another 30, 60, 90 and 120 min the samples were ⁰ C cooled Killmg immediately after removal of the same volume, at O buffer (20 mM NaN _3, 20 mM Tπs-HCl, pH 7.5, 5 mM MgCl ₂₎ was added for immediate Abzentπfugieren the cell pellet for 5 min at At 4 ° C and 15,000 rpm, the supernatant was discarded and the pellet either frozen at -80 ° C or immediately further worked up

cell disruption

The cell disruption was carried out with the "Hybaid RiboLyser ™ Cell Disruptor" (Fa Thermo Electron Corporation, Dreieich, Germany) This method is based on the mechanical destruction of the cell wall and the cell membrane with the help of 0.1 mm small glass beads (Sartonus BBI, Melsungen , Germany) The cells to be disrupted, which had previously been resuspended in lysis buffer II (3 mM EDTA, 200 mM NaCl), together with the glass beads, were placed in a glass In addition, acidic phenol was added to avoid degradation of the RNA by RNases. This tube was then clamped into the ribo-lyser, whereby under heavy debris, the glass beads collided with the cells, causing cell disruption

Total RNA isolation

After cell disruption, the RNA-containing aqueous phase is separated by centrifugation from the protein and cell fragments, the chromosomal DNA and the glass beads, and from this the RNA is purified using the instrument KmgFisher ml_ (Thermo Electron Corporation, Dreieich, Germany) using the MagNA Pure LC RNA Isolation Kit I (Fa Roche Diagnostics, Penzberg, Germany) isolated This purification is based on the binding of RNA to magnetic glass particles in the presence of chaotropic salts, which also cause the inactivation of RNases. The magnetic particles serve as transport of RNA between different reaction vessels filled with binding, washing and elution buffers The used KmgFisher mL is a type of pipetting robot that uses magnets to transport the particles with the bound RNA between the vessels and also uses them for mixing the samples In conclusion, the RNA is separated from the magnetic Particles dissolved and is purified

RNA quality and quantity control

The purification of the RNA is followed by quahtats and quantitative control. The Agilent Bιoanalyzer 2100 apparatus (Agilent Technologies, Berlin, Germany) used for this purpose makes it possible to analyze RNA on a lab-on-a-chιp scale together with the "RNA 6000 Nano Kit "from Agilent, the total RNA is separated by gel electrophoresis and thus offers the possibility of examining the jellyfish in terms of partial degradation and impurities. Here, πbosomal RNA (16 S and 23 S rRNA) is detected. These sites appear as clear bands It can be assumed that the RNA was not degraded in the course of processing and is therefore intact and can be introduced into the subsequent investigations. In addition, the exact concentration is also determined

transcriptome

The transcriptome analyzes were carried out using genomic slicheniformis DSM13 DNA microarrays, which had been prepared in a conventional manner (for example according to WO 95/11995 A1) and can be evaluated by an optical system. On these DNA microarrays, almost every gene was from B licheniformis in duplicate, so that two samples could be analyzed in parallel on the same chip and the values obtained could be averaged The principle of the measurement carried out is that the respective mRNA molecules are transcribed from the sample removed in vitro via reverse transcription into DNA, wherein one of the added deoxynucleotides carries a color marker. These labeled molecules are then labeled with the well-known sites of the Hybridized and the respective strength of the signal to be traced back to the fluorescence marker at the relevant sites signal detected When using two different fluorescence markers for a control and for a sample actually under investigation, which are brought simultaneously to hybridization and thus to the binding to the given probe compete, different color values are obtained which provide a measure of the ratio of the concentration of the control to the concentration of the sample

DUTP was chosen for this labeling, which was labeled with the fluorescent dye cyanine 3 or with cyanine 5. Thus, in each case 25 μg total RNA of the control (OD _50O 0.4) with the fluorescent dye cyanine 3 (Fa Amersham Biosciences Europe GmbH, Freiburg, Germany) and 25 μg total RNA of the respective stress test (transient phase, 30, 60, 90 and 120 mm) with the fluorescent dye cyanine 5 (GE Healthcare, Freiburg, Germany) marked the competitive hybridization of the two samples on the conventional, total genomi The DSMIS DNA microarray was performed for at least 16 hours at 42 ° C

After washing the arrays to remove non-specific binding, the optical readout of the arrays was performed using the ScanArray® Express Laser Scanner (PerkinElmer Life and Analytical Sciences, Rodgau-Jugesheim, Germany). All hybridizations were repeated using the samples with the other dye The quantitative evaluation of the arrays was performed using the ScanArray® Express software (available from PerkinElmer Life and Analytical Sciences Rodgau-Jugesheim, Germany) according to the manufacturer's instructions and under standard parameters

Using the controls of the Lucidea Score Card (GE Healthcare, Freiburg, Germany), the arrays were normalized and evaluated With the help of this "score card", which serves to control the efficiency and quality of the hybridization, were according to the manufacturer's information known control DNA and so-called spikes in the form of oligos were applied to the array and hybridized with complementary sequences in the hybridization Thus, one could control the success of hybridization and incorporation of the dyes after scanning The controls should be present in both samples in the same amount and thus after appear yellow or have a ratio between both channels of 1, respectively. The spikes are specific to the respective sample and are applied in different dilutions, ie they appear red or green after scanning for the respective sample For expression of the genes, mean values from the two hybridizations and the respective standard deviations were calculated. For a significant induction or a significant repression, the following threshold values for the ratio of the amount of RNA of the respective gene to the control value are considered: The genes whose RNA has a ratio of> 3 (ie at least one tripling) are considered as induced; clearly repressed are genes with an RNA ratio <0.3 (that is, a lowering to less than 30%). These results are listed in Example 2.

Example 2: Genes Induced by Nitrogen Manqel

Table 1 below lists all the 210 genes of Bacillus licheniformis DSM13 determined in Example 1 whose induction (amounting to at least the factor 3) was observed under the conditions of the nitrogen deficiency described in Example 1. In the first two columns the respective name of the derived protein or (if available) its abbreviation are given; the "BLi number" corresponds to the "locusjag" of entry AE017333 (bases 1 to 4,222,645) in the GenBank database (National Center for Biotechnology Information NCBI, National Institutes of Health, Bethesda, MD, USA; http: // /www.ncbi.nlm.nih.gov, as of December 2, 2004) of the entire genome of ß. licheniformis; This is followed by the factors observed at the times indicated above for increasing the concentration of the respectively associated mRNAs.

Table 1: The determined in Example 1 210 genes of Bacillus licheniformis DSM13, whose (at least the factor of 3 amounts) induction was observed under nitrogen deficiency (for explanations: see text).

Example 3 Genes Specifically Induced Under Nitrogen Deficiency

As shown in Table 1, under the conditions of the nitrogen deficiency described in Example 1 at any of the measured times, a total of 67 of the Bacillus licheniformis DSM 13 genes examined in Example 1 were induced by at least a factor of 8 have been induced to lack at least one other compound (data not shown) and therefore can not be considered as specific signals for nitrogen deficiency

Thus 49 genes remained, which were induced at least by a factor of 8 at any of the measured times and which can be classified as relatively specific. They are summarized in the following Table 2. Their column names are the same as in the previous example. Additionally, in the first column are the sequence numbers The particular DNA or amino acid sequences in the sequence listing belonging to the present application have particular features of the respective sequences which appear as free text in the sequence listing are supplemented under the heading gene name / gene function Table 2: The 62 genes of Bacillus licheniformis DSM13 determined in Example 1 whose nitrogen-induced induction at any of the measured times was at least 8 times (for explanations see text).

In Table 3 below, the same 49 genes are listed again in the order of magnitude of induction observed. In this order, the corresponding terms are given in German in the description section. The staggering of the claims is based on the reverse order.

Table 3: The 49 genes of Bacillus licheniformis DSM13 determined in Example 1 whose nitrogen-induced induction at any of the measured times was at least 8 times, in descending order of the maximum value measured in each case (last column).

Example 4: Real-Time RT-PCR Quantification of Selected Genes

With the help of the Real-Tιme-RT-PCR, it is possible to determine the absolute molecular numbers of specific transcripts in a sample. The LightCycler (Fa Roche Diagnostics, Penzberg, Germany) in conjunction with the "SYBR Green I" Kιt (Fa Roche Diagnostics) This method is based on the detection of the binding of the fluorescent dye to double-stranded DNA. The quantification of the specific mRNA molecules was carried out as described in Tobisch et al (2003, Quantification of Bactenal mRNA by One-Step RT-PCR Using the LightCycler System, BIOCHEMICA, Vol. 3, pages 5 to 8), with an external standard curve being generated for each mRNA to be tested

For this purpose, dilutions of known concentrations of / n-wfro transcπten the mRNA determined in Example 1 and Example 2 were measured using the LightCycler and then using the device-specific software created the standard curve For this purpose, had to be selected in advance for each mRNA to be examined specific primer (with the help of the software "Array Designer", available from PREMIER Biosoft International, Paolo Alto, USA), which enable synthesis of / n-prtro transcripts and PCR amplification in the LightCycler.

After making the external standard curve, the measurement started in the LightCycler. For the measurements, two different dilutions were used for each sample to be analyzed. In the LightCycler run, the specific transcript was then amplified with the respective primers and the incorporation of the dye was measured.

Using the LightCycler software and the script available on the website http://molbiol.ru/ger/scripts/01_07.html (December 2, 2004), it was possible to determine the exact number of molecules for selected transcripts. With the values obtained in this way and their relations to one another, the induction values indicated in Tables 1 and 2 were confirmed for the selected transcripts.

Example 5: Real-time RT-PCR quantification of the genes alnA, nrqB and tnrA

The genes glnA (SEQ ID NO. 13), noB (SEQ ID NO. 3) and tnrA were subjected to another real-time RT-PCR as described in the preceding example. TnrA is that shown in SEQ ID NO. 99 shown gene for a global, on the nitrogen metabolism regulation involved transcriptional regulator (indication in the sequence protocol: tnrA - transcriptional pleiotropic regulator involved in global nitrogen regulation - BLi 01490). This 333 bp gene is from ß. licheniformis DSM 13 and recorded in the above database under number BLi 01490. The deduced amino acid sequence is shown under SEQ ID NO. 100 indicated.

These measurements were again performed on the LightCycler using the "SYBR Green detection Kit". The gene-specific primers were derived using the Array Designer 2.0 program (PREMIER Biosoft International, Paolo Alto, USA) and purchased from Invitrogen (Karlsruhe, Germany). For the quantification of the specific mRNA, an external standard curve was generated by means of an / n-weekly transcript. The generation of the / nw ^' fro transcript was carried out using a T7 polymerase, the gene-specific PCR product and the "DIG RNA Labeling" kit (Roche Diagnostics, Penzberg, Germany) / π-wfro transcripts were determined photometrically.

A dilution series (1 ng to 100 fg final concentration) of the / nw ^' fro transcript was prepared and with MS2 RNA (final concentration 0.5 μg / μl; Roche Diagnostics) the forward and reverse primers and the LightCycler RNA master -SYBR Green 1 kit (Roche Diagnostics) as master mix, according to manufacturer's instructions, mixed. The standard curve for the specific gene was generated using the manufacturer's protocol for the RNA master SYBRGreen I kit (Amplification, Segment 2, Temperature: 57 ° C; Amplification, segment 3, incubation time: 16 s). The result of the LightCycler run was evaluated using the LightCycler software and the second-derivative-maximum method, and the quality of the RT-PCR products was checked by melting point determination.

For the measurements of the RNA samples, dilution levels of 500 ng to 5 ng of the total RNA were prepared and with MS2-RNA (final concentration 0.5 μg / μl), the specific primer pairs and the LightCycler-RNA-Master-SYBR-Green I -Kit mixed. For the real-time RT-PCR run with the LightCycler device, the same conditions were used as those used to create the standard curve.

The negative control was RNase-free water with MS2 RNA at a final concentration of 0.5 μg / μl. A selected dilution of a sample from the standard curve was carried during each LightCycler run.

The evaluation of the LightCycler measurements was carried out with the LightCycler-specific software. Using the standard curve and the second-derivative-maximum method, it was possible to determine the molecular amounts of the specific RNA in the sample measured.

The results summarized in the following Table 4 each refer to the amounts of molecules during the logarithmic phase, which have been set to 1 (control). Sampling took place at the time of the occurrence of the N-limitation, which, as explained above, is associated with the transition into the stationary phase (transient phase) and at 30, 60 and 120 minutes after this transition.

Table 4: Real-time RT-PCR quantification of the genes glnA, nrgB and tnrA with the entry of a nitrogen deficiency and the associated transition into the stationary phase

It can be seen that in this measurement all three genes glnA, nrgB and tnrA amplified with the onset of nitrogen deficiency and the consequent transition to the stationary phase, in the case of tnrA up to 15.24-fold stronger than during the exponential growth phase and associated more optimal Nitrogen supply can be expressed. They are thus suitable as marker genes according to the invention for indicating an incoming nitrogen deficiency. Description of the figures

Figure 1: Schematic representation of / W - // πe monitoring a bioprocess with electrical DNA chips according to the invention

The timely monitoring of the bioprocess takes place advantageously via the following steps:

1. Sampling, for example, from the fermentation of a microorganism;

2. cell digestion via routine methods;

3. RNA isolation via routine methods;

4. hybridization to a chip loaded according to the invention with nucleic acids (for example DNA) or nucleic acid analogs (for example, compounds which are difficult to hydrolyze, analogously constructed);

5. detection of the electrical signals of a correspondingly constructed electric chip; Alternatively, the recording of optical signals from an optical DNA chip would be possible;

6. Preferably computer-aided data evaluation.

When using electrical chips results in the current state of development an approximate total analysis time of less than 2 h, with the use of conventional optical DNA chips of about 12 h.

Claims

claims

1. Nucleic acid-binding chip doped with probes for at least three of the following 50 genes: kdgR, citA, gene coding for a putative protein (putative ABC transporter / amino acid permease) (homologue to SEQ ID NO. 91), htrA , ycnl, gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 41), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 53), yppF, yqjN, ggt, R, glnA, nrgA , yciC, yvtA, nrgB, gene encoding a conserved hypothetical protein of unknown function (homologue to SEQ ID NO 19), gene encoding a putative protein (ATP binding protein of a putative ABC transporter) (homologue to SEQ ID NO. 55), ycnJ, glnR, yvIA, yncE, yvlB, for a putative protein (putative hydrolase) encoding gene (homologue to SEQ ID NO: 47), trpF, ydfS, trpD, for a putative protein (putative phage capsid protein ) gene (homologue to SEQ ID NO. 21), ycnK, trpB, trpC, for a putative protein (putative transcriptional regulator) encoding gene (homolog to SEQ ID NO. 17), a gene coding for a putative protein (putative serine protease) (homologue to SEQ ID NO. 9), a gene coding for a putative protein (putative glycosylhydrolase / lysozyme) (homologue to SEQ ID NO. 85), for a putative protein ( putative malate synthase, EC 4.1.3.2) coding gene (homologue to SEQ ID NO. 45), gene coding for a putative protein (putative Na (+) - linked D-alanine-glycine permease) (homologue to SEQ ID NO. 49), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 95), nasD, gene encoding a putative protein (putative ammonium transporter) (homologue to SEQ ID NO: 63), ycdH, nasC, for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) encoding gene (homologue to SEQ ID NO: 15), nasB, trpE, pckA, gene coding for a putative protein (putative nitrogen regulatory protein P-II) (homologue to SEQ ID NO ), nasF, yrkC, gene coding for a hypothetical protein of unknown function (Homolog to SEQ ID NO. 81), tnrA, with the total number of different nitrogen specific metabolites not exceeding 80.

2. Nucleic acid-binding chip according to claim 1, increasingly preferably doped with the probes specified therein in the order given there.

Nucleic acid-binding chip according to claim 1 or 2, wherein at least one, more preferably two or three, of the probes are selected from the following 34 genes: gene coding for a conserved hypothetical protein of unknown function (homologue to SEQ ID NO ), for a putative protein (ATP binding protein of a putative ABC Transporter) (homologue to SEQ ID NO: 55), ycnJ, glnR, yvIA, yncE, yvlB, for a putative protein (putative hydrolase) encoding gene (homologue to SEQ ID NO: 47), trpF, ydfS, trpD, gene encoding a putative protein (putative phage capsid protein) (homologue to SEQ ID NO: 21), ycnK, trpB, trpC, gene encoding a putative protein (putative transcriptional regulator) (homologue to SEQ ID NO: 17 ), a gene coding for a putative protein (putative serine protease) (homologue to SEQ ID NO. 9), a gene coding for a putative protein (putative glycosylhydrolase / lysozyme) (homologue to SEQ ID NO. 85), for a putative protein (putative Malate synthase, EC 4.1.3.2) coding gene (homologue to SEQ ID NO. 45), for a putative protein (putative Na (+) - linked D-alanine-glycine permease) encoding gene (homologue to SEQ ID NO. 49), for a hypothetical protein of unknown function encoding gene (homologue to SEQ ID NO: 95), nasD, for a putative protein (pu tative ammonium transporter) gene (homologue to SEQ ID NO. 63), ycdH, nasC, gene coding for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) (homologue to SEQ ID NO: 15), nasB, trpE, pckA, for a putative protein (putative nitrogen regulatory protein P -Il) encoding gene (homologue to SEQ ID NO: 93), nasF, yrkC, gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 81), tnrA; preferably from the following 20 genes: trpC, gene coding for a putative protein (putative transcription regulator) (homologue to SEQ ID NO: 17), gene coding for a putative protein (putative serine protease) (homologue to SEQ ID NO. 9) , gene encoding a putative protein (putative glycosyl hydrolase / lysozyme) (homologue to SEQ ID NO: 85), gene coding for a putative protein (putative malate synthase, EC 4.1.3.2) (homologue to SEQ ID NO: 45), for a putative protein (putative Na (+) - linked D-alanine-glycine permease) encoding gene (homologue to SEQ ID NO: 49), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 95), nasD, for putative protein (putative ammonium transporter) encoding gene (homologue to SEQ ID NO: 63), ycdH, nasC, gene encoding a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) (homologue to SEQ ID NO: 15), nasB , trpE, pckA, for a putative protein (putative nitrogen Regulatory protein P-II) (homologue to SEQ ID NO. 93), nasF, yrkC, gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 81), tnrA; particularly preferred from the following 12 genes: nasD, gene coding for a putative protein (putative ammonium transporter) (homologue to SEQ ID NO. 63), ycdH, nasC, coding for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) Gene (homologue to SEQ ID NO: 15), nasB, trpE, pckA, gene encoding a putative protein (putative nitrogen regulatory protein P-II) (homologue to SEQ ID NO: 93), nasF, yrkC, for a hypothetical protein unknown function coding gene (homolog to SEQ ID NO. 81); most preferably from the following 4 genes: gene encoding a putative protein (putative nitrogen regulatory protein P-II) (homologue to SEQ ID NO: 93), nasF, yrkC, gene coding for a hypothetical protein of unknown function (homolog to SEQ ID NO. 81).

4. nucleic acid-binding chip according to one of claims 1 to 3, doped with at least 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 22, 24, 26 28, 30, 35, 40, 45 or 50 of said probes.

5. Nucleic acid-binding chip according to one of claims 1 to 4, wherein the total number of all different probes is increasingly preferably not more than 80, 75, 70, 65, 60, 55, 50, 40, 30, 20 or 10.

6. Nucleic acid-binding chip according to one of claims 1 to 5, wherein said probes are those which are responsive to the relevant, or most homologous, in vivo transcribable genes from the organism selected for the bioprocess, preferably those which are derived from the relevant, or most homologous, in vivo transcribable genes just this organism.

The nucleic acid-binding chip according to claim 6, wherein the organism selected for the bioprocess is a representative of unicellular eukaryotes, Gram-positive or Gram-negative bacteria.

8. A nucleic acid-binding chip according to claim 7, wherein the unicellular eukaryotes are protozoa or fungi, including in particular yeast, especially Saccharomyces or Schizosaccharomyces.

Nucleic acid-binding chip according to claim 7, wherein the Gram-positive bacteria are Coryneform bacteria or those of the genera Staphylococcus, Corynebacteria or Bacillus, in particular of the species Staphylococcus carnosus, Corynebacterium glutamicum, Bacillus subtilis, B. licheniformis, B. amyloliquefaciens B. agaradherens, B. stearothermophilus, B. globigii or B. lentus, and especially B. licheniformis.

10. A nucleic acid-binding chip according to claim 7, wherein the Gram-negative bacteria are those of the genera E. coli or Klebsiella, in particular derivatives of Escherichia coli K12, of Escherichia coli B or Klebsiella planticola, and whole especially derivatives of the strains Escherichia coli BL21 (DE3), E. coli RV308, E. coli DH5α, E. coli JM109, E. coli XL-1 or Klebsiella planticola (Rf).

11. A nucleic acid-binding chip according to any one of claims 1 to 10, wherein at least one, more preferably more of said probes is / are derived from the sequences shown in the sequence listing under the numbers SEQ ID NO. 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97 and 99 are.

The nucleic acid-binding chip according to any one of claims 1 to 11, additionally doped with at least one probe for an additional gene, in particular one which is in a metabolic-related relation to the process-related additionally expressed gene (s) especially for one of these or this self.

13. Nucleic acid-binding chip according to claim 12, wherein the process-related additionally expressed gene is that for a commercially useful protein, in particular an amylase, cellulase, lipase, oxidoreductase, a hemicellulase or protease, or one of which a synthesis route for a low molecular weight chemical compound or at least partially regulated.

14. Nucleic acid-binding chip according to one of claims 1 to 13, wherein one, preferably a plurality of said probes single-stranded, is provided in the form of the codogenic strand / are.

15. Nucleic acid-binding chip according to one of claims 1 to 14, wherein one, preferably more of said probes in the form of a DNA or a nucleic acid analog, preferably a nucleic acid analogue is provided / become.

16. Nucleic acid-binding chip according to one of claims 1 to 15, wherein one, preferably a plurality of said probes gene / includes gene regions / which are rewritten by the organism to be examined in mRNA, in particular the gene regions which are near the 5 'end of lie mRNA.

17. A nucleic acid-binding chip according to any one of claims 1 to 16, wherein one, preferably more of said probes to fragments of the respective nucleic acids responds / respond, in particular those which have a low level of secondary folding in the relevant mRNA, based on the respective total mRNA.

18. Nucleic acid-binding chip according to one of claims 1 to 17, wherein one, preferably more of said probes has a length of less than 200 nucleotides, preferably less than 100 nucleotides, more preferably from 20 to 60 nucleotides, most preferably from 45 to 55 nucleotides.

19. Nucleic acid-binding chip according to one of claims 1 to 18, wherein an electrical signal is triggered by the binding of the mRNA to the relevant said probe.

20. Simultaneous use of nucleic acid or nucleic acid analogue probes for at least three of the following 50 genes: kdgR, citA, gene coding for a putative protein (putative ABC transporter / amino acid permease) (homologue to SEQ ID NO. 91 ), htrA, ycnl, gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 41), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 53), yppF, yqjN, ggt, as R, glnA, nrgA, yciC, yvtA, nrgB, gene encoding a conserved hypothetical protein of unknown function (homologue to SEQ ID NO: 19), gene encoding a putative protein (ATP binding protein of a putative ABC transporter) (homologue to SEQ ID No. 55), ycnJ, glnR, yvIA, yncE, yvlB, for a putative protein (putative hydrolase) encoding gene (homologue to SEQ ID NO: 47), trpF, ydfS, trpD, for a putative protein (putative phage Capsid protein) encoding gene (homologue to SEQ ID NO. 21), ycnK, trpB, trpC, gene encoding a putative protein (putative transcriptional regulator) (homologue to SEQ ID NO. 17), a gene coding for a putative protein (putative serine protease) (homologue to SEQ ID NO. 9), a gene coding for a putative protein (putative glycosylhydrolase / lysozyme) (homologue to SEQ ID NO. 85), for a putative protein ( putative malate synthase, EC 4.1.3.2) coding gene (homologue to SEQ ID NO. 45), gene coding for a putative protein (putative Na (+) - linked D-alanine-glycine permease) (homologue to SEQ ID NO. 49), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 95), nasD, gene encoding a putative protein (putative ammonium transporter) (homologue to SEQ ID NO: 63), ycdH, nasC, for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) encoding gene (homologue to SEQ ID NO: 15), nasB, trpE, pckA, gene coding for a putative protein (putative nitrogen regulatory protein P-II) (homologue to SEQ ID NO ), nasF, yrkC, gene coding for a hypothetical protein of unknown function (Homolog to SEQ ID NO. 81), tnrA, bound to a nucleic acid-binding chip, preferably to the same, for Determination of the physiological state of a biological process going through an organism.

21. Use according to claim 20, wherein the total number of all nitrogen specific for the different different probes is not more than 80.

22. Use according to claim 20 or 21, wherein the probes specified in claim 20 are increasingly used in the order given there.

23. Use according to any one of claims 20 to 22, wherein at least one, more preferably two or three of the nucleic acid or nucleic acid analog probes are specific for genes from the following 34 genes: gene coding for a conserved hypothetical protein of unknown function (Homologue to SEQ ID NO: 19), for a putative protein (ATP binding protein of a putative ABC transporter) encoding gene (homologue to SEQ ID NO: 55), ycnJ, glnR, yvIA, yncE, yvlB, for a putative protein (putative hydrolase) encoding gene (homologue to SEQ ID NO: 47), trpF, ydfS, trpD, gene encoding a putative protein (putative phage capsid protein) (homologue to SEQ ID NO 21), ycnK, trpB, trpC, gene coding for a putative protein (putative transcriptional regulator) (homologue to SEQ ID NO: 17), gene coding for a putative protein (putative serine protease) (homologue to SEQ ID NO: 9), for a putative protein (putative Glycosyl hydrolase / lysozyme) of the gene (homolog to SEQ ID NO. 85), gene encoding a putative protein (putative malate synthase, EC 4.1.3.2) (homologue to SEQ ID NO: 45), gene coding for a putative protein (putative Na (+) - linked D-alanine-glycine permease) (homolog SEQ ID NO: 49), a gene coding for a hypothetical protein of unknown function (homologue to SEQ ID NO: 95), nasD, gene coding for a putative protein (putative ammonium transporter) (homologue to SEQ ID NO: 63), ycdH, nasC, gene encoding a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) (homologue to SEQ ID NO: 15), nasB, trpE, pckA, gene encoding a putative protein (putative nitrogen regulatory protein P-II) (Homologue to SEQ ID NO: 93), nasF, yrkC, gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 81), tnrA; preferably for genes from the following 20 genes: trpC, gene encoding a putative protein (putative transcription regulator) (homologue to SEQ ID NO: 17), gene coding for a putative protein (putative serine protease) (homologue to SEQ ID NO. 9), gene coding for a putative protein (putative glycosyl hydrolase / lysozyme) (homologue to SEQ ID NO: 85), gene coding for a putative protein (putative malate synthase, EC 4.1.3.2) (homologue to SEQ ID NO: 45), for a putative Protein (putative Na (+) - linked D-alanine-glycine permease) encoding gene (homologue to SEQ ID NO. 49), gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO. 95), nasD, for a putative Protein (putative ammonium transporter) encoding gene (homologue to SEQ ID NO: 63), ycdH, nasC, gene coding for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS) (homologue to SEQ ID NO: 15), nasB, trpE, pckA, gene encoding a putative protein (putative nitrogen regulatory protein P-II) (homologue to SEQ ID NO: 93), nasF, yrkC, gene encoding a hypothetical protein of unknown function (homologue to SEQ ID NO: 81) , tnrA; particularly preferred for genes from the following 12 genes: nasD, for a putative protein (putative ammonium transporter) encoding gene (homologue to SEQ ID NO. 63), ycdH, nasC, for a hypothetical protein (close homolog to aldehyde dehydrogenase DhaS nasB, trpE, pckA, gene coding for a putative protein (putative nitrogen regulatory protein P-II) (homologue to SEQ ID NO: 93), nasF, yrkC, for a gene encoding it (homologue to SEQ ID NO: 15) hypothetical protein of unknown function encoding gene (homologue to SEQ ID NO. 81); very particularly preferred for genes from the following 4 genes: gene coding for a putative protein (putative nitrogen regulatory protein P-II) (homologue to SEQ ID NO. 93), nasF, yrkC, gene coding for a hypothetical protein of unknown function (homolog to SEQ ID NO. 81).

24. Use according to one of claims 20 to 23 of simultaneously at least 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 22, 24, 26 28, 30, 35, 40, 45 or 50 of the probes mentioned.

25. Use according to any one of claims 20 to 24, wherein the total number of all different probes is increasingly preferably not more than 80, 75, 70, 65, 60, 55, 50, 40, 30, 20 or 10.

26. Use according to one of claims 20 to 25 for determining a change in the nitrogen metabolism of the organism passing through the biological process, preferably for the detection of a nitrogen deficiency state.

27. Use according to any one of claims 20 to 26, wherein at least one, increasingly preferably several of said probes are derived from the sequences which are listed in the sequence listing under the numbers SEQ ID NO. 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97 and 99 are.

28. A method of determining the physiological state of a biological process-passing organism by use of a nucleic acid-binding chip according to any one of claims 1 to 19.

29. The method of claim 28, wherein a change in the nitrogen metabolism of the organism passing through the biological process is determined, preferably a nitrogen deficiency state.

30. The method of claim 28 or 29, wherein the organism selected for the bioprocess is a representative of unicellular eukaryotes, Gram-positive or Gram-negative bacteria.

31. The method of claim 30, wherein the unicellular eukaryotes are protozoa or fungi, including in particular yeast, especially Saccharomyces or Schizosaccharomyces.

32. The method according to claim 30, wherein the Gram-positive bacteria are Coryneform bacteria or those of the genera Staphylococcus, Corynebacteria or Bacillus, in particular the species Staphylococcus carnosus, Corynebacterium glutamicum, Bacillus subtilis, B. licheniformis, B. amyloliquefaciens, B. agaradherens, B. stearothermophilus, B. globigii or S. lentus, and especially B. licheniformis.

33. The method of claim 30, wherein the gram-negative bacteria are those of the genera E. coli or Klebsiella, in particular derivatives of Escherichia coli K12, Escherichia coli B or Klebsiella planticola, and more particularly derivatives of the strains Escherichia coli BL21 (DE3), E. coli RV308, E. coli DH5α, E. coli JM109, E. coli XL-1 or Klebsiella planticola (Rf).

34. The method of claim 33 or preferably 32, wherein those of said probes are used which are of the SEQ ID NO. 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97 or 99 are.

35. The method according to any one of claims 28 to 34, wherein the determination of the physiological state at different times of the same process is carried out, preferably using a plurality of identically constructed nucleic acid-binding chips, particularly preferably the same nucleic acid-binding chip.

36. The method according to any one of claims 28 to 35, wherein the process is a fermentation, in particular the fermentative production of a commercially useful product, more preferably is the preparation of a protein or a low molecular weight chemical compound.

37. The method of claim 36, wherein the low molecular weight chemical compound is a natural product, a food supplement or a pharmaceutically relevant compound.

38. The method of claim 36, wherein the protein is an enzyme, in particular one of the group of α-amylases, proteases, cellulases, lipases, oxidoreductases, peroxidases, laccases, oxidases and hemicellulases.

39. Use of a nucleic acid-binding chip according to any one of claims 1 to 19 for the determination of the physiological state of a biological process going through an organism.

40. Use according to claim 39, wherein a change in the nitrogen metabolism of the organism passing through the biological process is determined, preferably a nitrogen deficiency state.

41. Use according to claim 39 or 40, wherein the organism selected for the bioprocess is a representative of unicellular eukaryotes, Gram-positive or Gram-negative bacteria.

42. Use according to claim 41, wherein the unicellular eukaryotes are protozoa or fungi, including in particular yeast, especially Saccharomyces or Schizosaccharomyces.

43. Use according to claim 41, wherein the Gram-positive bacteria are Coryneform bacteria or those of the genera Staphylococcus, Corynebacteria or Bacillus, in particular of the species Staphylococcus carnosus, Corynebacterium glutamicum, Bacillus subtilis, B. licheniformis, B. amyloliquefaciens, B agaradherens, B stearothermophilus, B globigu or B lentus, and more particularly B licheniformis

Use according to claim 41, wherein the Gram-negative bacteria are those of the genera E coli or Klebsiella, in particular derivatives of Escherichia coli K12, Escherichia coli B or Klebsiella planticola, and more particularly derivatives of the strains Escherichia coli BL21 (DE3 ) E. coli RV308, E. coli DH5α, E. coli JM109, E. coli XL-1 or Klebsiella planticola (Rf)

Use according to claim 44 or preferably 43, wherein those of said probes are used which are of the SEQ ID Nos. 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97 or 99 are derived

Use according to one of claims 39 to 45, wherein the determination of the physiological state is performed at different times of the same process, preferably using a plurality of identically constructed nucleic acid-binding chips, more preferably the same nucleic acid-binding chip

Use according to any one of claims 39 to 46, wherein the process is a fermentation, in particular the fermentative production of a commercially useful product, more preferably the production of a protein or a low-molecular chemical compound

Use according to claim 47, wherein the low molecular weight chemical compound is a natural product, a food supplement or a pharmaceutically relevant compound

Use according to claim 47, wherein the protein is an enzyme, in particular one of the group of α-amylases, proteases, cellulases, lipases, oxidoreductases, peroxidases, laccases, oxidases and hemicellulases